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ABSTRACT 
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease that affects 
primarily the joints. RA leads to cartilage destruction and bone erosion, with substantial 
loss of quality of life. RA is associated with an increased risk of cardiovascular disease, 
osteoporosis, gastrointestinal disorders, thus increasing disability and mortality. RA 
affects 0.5-1% of the adult population, and is three times more common among women 
than among men. Twin studies have shown that the relative contribution of genetic 
factors to RA is about 50%, leaving the remaining part to environmental factors. Few 
epidemiological studies have examined risk factors for RA. Even though cigarette 
smoking is an established risk factor for RA, the role of its characteristics in the 
development of the disease is less clear. In addition, analyses of other risk factors have 
led to inconclusive and often conflicting results. 
 
Aims of this thesis were: 1) to analyze the association between characteristics of 
cigarette smoking (intensity, duration and cessation) and RA risk in a population-based 
prospective cohort study and by summarizing published evidence; 2) to evaluate the 
association of alcohol consumption and risk of RA; 3) to estimate the dose-response 
relationship between long-chain n-3 polyunsaturated fatty acids (PUFAs) and risk of 
RA; 4) to evaluate long-term intake of alcohol and long-chain n-3 PUFAs, as well as 
the long-term consumption of fish in relation to RA; 5) to prospectively evaluate the 
association between physical activity and RA. 
 
The data used to assess the association between selected exposures and the 
development of RA were obtained by means of questionnaires administered in 1987 
and 1997 to the Swedish Mammography Cohort. Among the 35 187 women that did 
not have RA or non-RA joint conditions before the start of follow-up in 2003, 224 
developed RA before 2010. Results showed a twofold increased risk among current 
smokers compared with never smokers, even when their exposure to smoking was low 
(<7 cigarettes per day). The risk of RA decreased over time following smoking 
cessation, but remained elevated after more than 15 years since smoking cessation 
compared with never smokers. Moderate alcohol consumption (a median of 6 glasses 
of alcohol per week) was associated with a 37% decreased risk of RA. In addition, 
long-chain n-3 PUFA dietary intake was inversely associated with RA risk, and women 
with an intake of more than 0.21 grams per day of long-chain n-3 PUFAs had a 35% 
decreased risk compared with women with a lower intake (≤0.21 grams per day). A 
consistent moderate long-term intake of both alcohol and long-chain n-3 PUFAs was 
associated with a halved risk of RA. Long-term consumption of fish was inversely 
associated with RA, but after adjustment for their content of long-chain n-3 PUFAs the 
association disappeared. Leisure-time activity (combination of walking and exercising) 
was associated with a decreased risk of RA. 
 
Results from this thesis showed that modifiable lifestyle factors, including smoking, 
alcohol consumption, long-chain n-3 PUFAs intake and physical activity, are 
associated with RA development. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To Giorgio 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
LIST OF PUBLICATIONS 
I. Di Giuseppe D, Orsini N, Alfredsson L, Askling J, Wolk A. 
Cigarette smoking and smoking cessation in relation to risk of rheumatoid 
arthritis in women. Arthritis Res Ther. 2013 Apr 22;15(2):R56. 
 
II. Di Giuseppe D, Discacciati A, Orsini N, Wolk A. 
Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-
analysis. Arthritis Res Ther. 2014 Mar 5;16(2):R61 
 
III. Di Giuseppe D, Alfredsson L, Bottai M, Askling J, Wolk A. 
Long term alcohol intake and risk of rheumatoid arthritis in women: a 
population-based cohort study. BMJ, 2012 Jul 10;345:e4230 
 
IV. Di Giuseppe D, Wallin A, Bottai M, Askling J, Wolk A. 
Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and 
risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum 
Dis. 2013 Aug 12. 
 
V. Di Giuseppe D, Bottai M, Askling J, Wolk A. 
Physical activity and risk of rheumatoid arthritis in women: a population-
based prospective study. Submitted 
 
   
  
RELATED PUBLICATIONS 
Wallin A, Di Giuseppe D, Burgaz A, Håkansson N, Wolk A. 
Validity of food frequency questionnaire-based estimates of long-term long-chain n-3 
polyunsaturated fatty acid intake. Eur J Nutr. 2013 Jul 26 
 
Wallin A, Di Giuseppe D, Orsini N, Patel PS, Forouhi NG, Wolk A. 
Fish consumption, dietary long-chain n-3 fatty acids, and risk of type 2 diabetes: 
systematic review and meta-analysis of prospective studies. Diabetes Care, 2012 
Apr;35(4):918-29. 
 
Di Giuseppe D, Crippa A, Orsini N, Wolk A. 
Fish consumption and risk of rheumatoid arthritis: a dose-response meta-analysis. 
Submitted 
 
Di Giuseppe D, Wolk A. 
Diet and rheumatoid arthritis development: what does the evidence say? International 
Journal of Clinical Rheumatology, accepted for publication  
 
 
 
  
CONTENTS 
1! Introduction ................................................................................................... 1!
2! Background ................................................................................................... 2!
2.1! Rheumatoid arthritis ........................................................................... 2!
2.2! Environmental risk factors ................................................................. 8!
2.2.1! Cigarette smoking................................................................... 8!
2.2.2! Alcohol ................................................................................... 9!
2.2.3! Physical activity...................................................................... 9!
2.2.4! Diet ........................................................................................ 10!
2.2.5! Other factors ......................................................................... 12!
3! Aims ............................................................................................................ 13!
4! Subjects and methods ................................................................................. 14!
4.1! Study population ............................................................................... 14!
4.1.1! Exclusions ............................................................................. 15!
4.2! Exposures assessment ....................................................................... 15!
4.2.1! Validation ............................................................................. 18!
4.2.2! Missing data .......................................................................... 19!
4.3! Case definition .................................................................................. 20!
4.3.1! The Patient Register ............................................................. 20!
4.3.2! The Swedish Rheumatology Register .................................. 21!
4.3.3! Identification of incident cases ............................................ 21!
4.4! Statistical methods ............................................................................ 22!
4.4.1! Survival analysis ................................................................... 22!
4.4.2! Population Attributable Risk ................................................ 25!
4.4.3! Meta-analysis ........................................................................ 26!
5! Results ......................................................................................................... 31!
5.1! Characteristics of the study population ............................................ 31!
5.2! Main results ....................................................................................... 31!
5.2.1! Cigarette smoking and rheumatoid arthritis (Paper I) ......... 31!
5.2.2! Alcohol and rheumatoid arthritis (Paper III) ....................... 33!
5.2.3! Long-chain n-3 PUFA and rheumatoid arthritis (Paper IV) 34!
5.2.4! Physical activity and rheumatoid arthritis (Paper V) .......... 36!
5.3! Analyses of Long-term exposures .................................................... 37!
5.4! Sensitivity analyses ........................................................................... 39!
5.4.1! Alternative definitions of start of follow-up ........................ 39!
5.4.2! Presence of prevalent cases .................................................. 40!
5.4.3! Missing values ...................................................................... 41!
5.4.4! Fish-oil supplements (Paper IV) .......................................... 41!
5.5! Population Attributable Risk ............................................................ 42!
5.6! Meta-analysis (Paper II) ................................................................... 42!
6! Discussion ................................................................................................... 44!
6.1! Methodological considerations ........................................................ 44!
6.1.1! Random error ........................................................................ 44!
6.1.2! Systematic error .................................................................... 45!
6.1.3! Meta-analysis ........................................................................ 50!
6.2! Main findings and general discussion .............................................. 51!
  
6.2.1! Cigarette smoking and rheumatoid arthritis ........................ 51!
6.2.2! Alcohol consumption and rheumatoid arthritis ................... 52!
6.2.3! Long-chain n-3 PUFAs and rheumatoid arthritis ................ 53!
6.2.4! Physical activity and rheumatoid arthritis ........................... 54!
7! Conclusions ................................................................................................ 55!
8! Future research ........................................................................................... 56!
9! Acknowledgements .................................................................................... 57!
10! References .................................................................................................. 59!
 
  
LIST OF ABBREVIATIONS 
 
ACPA Anti-citrullinated peptide antibody 
ACR American college of rheumatology 
BMI Body mass index 
CI Confidence interval 
CRP C-reactive protein  
DHA Docosahexaenoic acid 
DMARDs Disease-modifying anti-rheumatic drugs 
DPA Docosapentaenoic acid 
EIRA Epidemiological Investigation of Rheumatoid Arthritis 
EPA Eicosapentaenoic acid  
ESR Erythrocyte sedimentation rate 
EULAR European league against rheumatism 
Fc Fragment crystallizable  
FFQ Food frequency questionnaire 
HLA Human leukocyte antigen 
HR Hazard ratio 
IPR Inpatient Register 
MHC Major histocompatibility complex 
MMPs Matrix metallaproteinases 
NBHW National board of health and welfare 
NOQAS Newcastle–Ottawa Quality Assessment Scale 
NSAIDs Non-steroid anti-inflammatory drugs  
OPR Outpatient Register 
PAR Population attributable risk 
PIN Personal identification number 
PPF Population prevented fraction 
PPV Positive predictive value 
PUFA Polyunsaturated fatty acids 
RA Rheumatoid arthritis 
RANKL Receptor activator of nuclear factor kappa-B ligand  
RF Rheumatoid factor 
RR Relative risk 
SMC Swedish Mammography Cohort 
SRR Swedish Rheumatology Register 
TNF Tumor necrosis factor 
YLD Years lived with disability 
 

   1 
1 INTRODUCTION 
 
Rheumatoid arthritis is an autoimmune inflammatory disease that affects the joints.
1
 
Rheumatoid arthritis affects 0.5-1% of adults in developed countries
2 3
 and has 
tremendous influences on quality of life and on costs for both individuals and society.
4
 
 
Twin studies have shown that the contribution of genetic factors to rheumatoid arthritis 
is about 50%, leaving the remaining part to environmental factors.
5
 Cigarette smoking 
is one of the few environmental factors that has been linked to the development of 
rheumatoid arthritis. Other lifestyle and environmental factors, such as diet and 
physical activity, have been examined in very few studies with mixed results. 
 
The main aim of this thesis was to examine the role of cigarette smoking, alcohol 
consumption, diet (i.e. long-chain n-3 polyunsaturated fatty acids), and physical activity 
in the etiology of rheumatoid arthritis.  
 
 
 
 2 
2 BACKGROUND 
 
2.1 RHEUMATOID ARTHRITIS 
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease that 
principally attacks the joints. RA is classified as an autoimmune disease because the 
immune system attacks the individual’s own cells and tissues. RA can be characterized 
by the production of two known antibodies, rheumatoid factor (RF) and anti-
citrullinated peptide antibody (ACPA), against common autoantigens that are widely 
expressed outside the joints. RA is a chronic inflammatory disease, because of the 
imbalance of inflammatory cytokines, which causes joint destruction.  
 
RA is a complex genetic disease, with several genes, environmental factors, and 
stochastic factors acting in concert to cause pathological events (Figure 1).
1
 Twin 
studies have shown that the relative contribution of genetic factors to RA is about 50%, 
leaving the remaining part to environmental factors.
5
 An issue in RA prevention is the 
timing of exposure to environmental factors, since some studies have suggested that the 
influence of environmental risk factors on RA could begin even before birth.
6 7
  
 
 
 
Figure 1. Hypothetical model for molecular pathogenesis of ACPA-positive 
rheumatoid arthritis. Reprinted with permission from Lancet
1
  
ACPA: anti-citrullinated peptide antibody, RF: rheumatoid factor, CP: citrullinated proteins and peptide, 
MHC: major histocompatibility complex, TCR: T cell receptor, FcγR: fragment crystallizable gamma 
receptor.  
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2.1.1.1 Pathogenesis 
RA can be considered a clinical syndrome that includes several disease subsets.
8
 These 
different subsets involve several inflammatory cascades, which all lead to persistent 
synovial inflammation and damage to articular cartilage and bone,
9
 by actions that 
include the innate as well as the adaptive immune system and imbalances in regulation 
of cytokines and other inflammatory mediators. 
 
One such key inflammatory cascade in RA pathogenesis includes overproduction and 
overexpression of tumor necrosis factor (TNF).
10
 TNF overproduction has several 
causes and leads to overproduction of multiple cytokines including interleukin 6, which 
also drives persistent inflammation and joint destruction.
11
 
 
Synovial inflammation is characterized by the presence of many interacting immune 
cells.
1
 Antigen-presenting cells, such as B cells, communicate with T cells through the 
Major Histocompatibility Complex (MHC). Macrophages activated by signals from T 
cells and by immune complexes produce many proinflammatory cytokines, including 
TNF, interleukin 1 and interleukin 6. These molecules enhance cytokine release, 
production of cartilage-destructive enzymes and expression of bone destruction-related 
molecules, such as RANKL (receptor activator of nuclear factor kappa-B ligand).
12
 
 
Cartilage destruction is caused by matrix metalloproteinases (MMPs), molecules that 
degrade the structural proteins of the extracellular matrix of cartilage and that are 
released by proinflammatory cytokines. Bone erosion is caused by osteoclast activated 
from macrophage-like precursors after stimulation by RANKL,
13
 by T cells that act 
directly on osteoclasts and by fibroblast-like synoviocytes active in pannus tissue.
14
  
Fibroblast-like synoviocytes show abnormal behavior in RA that also leads to fibroblast 
invading cartilage which correlates with joint destruction.
15
 However, it is still not clear 
if RA starts in the joints and then spreads out into the bones or the other way around 
(Figure 2).
16
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Figure 2. Immunological pathways in the arthritic joint (upper part shows joint 
inflammation, lower part joint destruction). Reprinted with permission from Lancet
1
 
CD: cluster of differentiation, MHC: major histocompatibility complex, TCR: T cell receptor, TNF: 
tumor necrosis factor, TH17: T helper 17 cells, RANKL: receptor activator of nuclear factor kappa-B 
ligand, MMP: matrix metalloproteinase, M-CSF: macrophage colony-stimulating factor 
 
 
 
2.1.1.2 Genes  
The reported association between certain HLA-D/DR alleles and risk for RA suggests 
that MHC class II-dependent T-cell and B-cell activation are major drivers of the 
disease.
17
 Most of HLA-DR alleles involved in RA have a common aminoacid motif, 
named the shared epitope, in the β-chain of the HLA-DR molecule.
18
 A second 
identified gene involved in the development of RA is PTPN22, a gene that codes for a 
tyrosine phosphatase which has a role in T-cell and B-cell signaling.
19
 HLA DRB1 
shared epitope and PTPN22 risk alleles are associated only with ACPA or RF positive 
RA, thus indicating that subsets of RA should be analyzed as separate entities. One of 
the HLA alleles thought to be involved in ACPA negative RA is HLA DRB1*03, 
however this association needs to be confirmed.
20
 
 
2.1.1.3 Treatment strategies 
Treatment strategies of RA include early dynamic and tightly controlled treatment and 
targeted approaches.  
 
Pharmaceutical treatments for RA include cortisone, non-steroid anti-inflammatory 
drugs (NSAIDs) and disease-modifying anti-rheumatic drugs (DMARDs, such as 
methotrexate, sulfadalazine, hydroxychloroquine, leflunomide, and glucocorticoids).  
   5 
 
In addition, biological treatments include TNF-alpha (infliximab, etanercept, 
adalimumab) and interleukin 1 (anakinra) blockers and inhibitors, and agents targeting 
T and B lymphocytes (abatacept and rituximab). Treatment with inflammatory 
inhibitors should be administered effectively and as early as possible in the course of 
the disease to reduce future joint damage and functional disorders.
1
  
 
Surgical treatments, such as arthroplasty, arthrodesis, synovectomy of joints and 
tendons, nerve decompression and reconstructive tendon surgery, have decreased in the 
past years in favor of biological treatments. 
 
2.1.1.4 Co-morbidities 
Co-morbid conditions are common in patients with RA.
21
 Co-morbidity means the 
existence of two or more diseases in the same person. Some co-morbidities, as 
cardiovascular disease, are associated with RA, and their frequencies and impact are 
increased in RA patients. Co-morbidities increase disability and shorten life 
expectancy, thus increasing impact and mortality of RA.
22 23
 
 
Cardiovascular diseases are the most important co-morbidities in those with RA. 
Patients with RA are at increased risk of ischemic heart disease
24
 and heart failure
25
 
compared to the general population. The increased cardiovascular risk in RA patients 
can be explained by a higher prevalence of traditional cardiovascular risk factors, such 
as smoking, or by effects of treatments, such as NSAIDs, corticosteroid and DMARDs 
(methotrexate).
21
 Treatments for RA are also related to gastrointestinal disorders,
26
 as 
well as malignancies
27
 and infections.
28
  
 
Osteoporosis is another co-morbidity observed in RA patients, due to a shared 
mechanism via cytokine-induced osteoclast activation. RA patients also have a higher 
frequency and severity of periodontal disease, which shares common RA risk factors, 
including smoking and HLA-DR B1 04 alleles, as well as pathological processes.
29
 
 
2.1.1.5 Incidence and prevalence 
Rheumatoid arthritis affects 0.5-1% of adults in developed countries.
2 3
 The disease is 
three times more frequent in women than in men. Onset of RA is usually in middle-age, 
but it may occur at any ages. The prevalence increases with age.
30
  Incidence ranges 
from 5 to 50 per 100 000 adults in developed countries and increases with age as well.
31
 
The reported disease prevalence is higher in northern Europe and North America 
compared with developing countries, which may reflect differences in risk factors as 
well as case ascertainment and survival.
32
 
 
A recent study estimated the RA incidence in Sweden.
33
 Using the Swedish National 
Patient Register, 8 826 incident cases were identified during the period 2006-2008 in a 
population of 7 331 508 people aged ≥18 years. The overall incidence was 41 per 
100 000 (56 for women, 25 for men). The incidence increased with age and peaked in 
the 70-79 year age group for both women and men (Figure 3). 
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Figure 3. Mean annual incidence of adult rheumatoid arthritis per 100 000 women in 
Sweden, 2006-2008
33
 
 
 
2.1.1.6 Costs and quality of life 
RA is associated with substantial loss of quality of life and elevated costs for both 
patients and society.  
 
Costs related to RA include direct medical and non-medical cost and indirect costs (i.e. 
productivity loss, increased co-morbidities, burden for caregivers, and premature 
mortality).
34 35
 Introduction of biological drugs increased considerably the costs related 
to drug use, as they are 30-40 times more costly than traditional DMARDs.
36
 RA-
attributable direct health care costs have been estimated at €14 billion per year in 
Europe.
4
 Costs of RA management increase with increasing disease severity, in 
particular with functional disability. In Sweden, the costs of RA increased by one third 
between 1990 and 2010, and were approximately €600 million in 2010.
37
 Of the total 
costs, drug related costs increased from 3% to 33% between 1990 and 2010, while 
indirect costs (including sick leave and disability pension) decreased. 
 
The decrease in quality of life is considerable in patients with RA that regularly score 
among the groups with lowest utility values.
4
 Utility may be defined as “a cardinal 
measure of the preference for, or desirability of, a specific level of health status or 
specific health outcome” and range between 0 and 1.
38
 Mean utilities in population 
samples of RA have been estimated to be between 0.45 and 0.55. As a comparison, only 
multiple sclerosis appears to have a similar effect on quality of life. Moreover, RA 
accounts for 0.8% of total global Years Lived with Disability (YLD), around the same 
percentage as obsessive-compulsive disorders and meningitis.
39
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2.1.1.7 Diagnosis 
A diagnosis of RA prior to 2010 was given according to the classification criteria 
defined by the American College of Rheumatology (ACR) in the mid-1980s.
40
 
According to these criteria, a patient was defined as having RA if he or she met at least 
four of the following seven criteria: 
 
• Morning stiffness lasting at least 1 hour, present for at least 6 weeks 
• At least three joint areas simultaneously with soft-tissue swelling or fluid, for at 
least 6 weeks 
• At least one area swollen in a wrist, metacarpaophalangeal, or proximal 
interphalangeal joint, for at least 6 weeks 
• Simultaneous involvement of the same joint areas on both sides of the body, for 
at least 6 weeks 
• Subcutaneous nodules seen by a doctor 
• Positive rheumatoid factor (RF) 
• Radiographic changes on hand and wrist radiographs (erosions or unequivocal 
bony decalcification). 
  
However, these criteria have been criticized due to the low sensitivity in detecting early 
disease. In particular, two of the seven criteria (presence of nodules and erosions) are 
generally not present in early stages of the disease. Therefore, there was a need for new 
criteria that could take into account the disease pathogenesis that can be used for early 
diagnosis and treatment decisions. In 2010, the ACR in collaboration with the 
European League Against Rheumatism (EULAR) produced new criteria.
41
 The new 
criteria were applied to patients with at least 1 joint with definite clinical synovitis 
(swelling) and with the synovitis not better explained by another disease (such as 
systemic lupus erythematosus, psoriatic arthritis, and gout). The 2010 criteria was 
based on a score of four categories and 6 out of 10 is needed for classification of a 
patient as having definite RA: 
 
A. Joint involvement 
• Score 0 if 1 large joint                         
• Score 1 if 2-10 large joints                    
• Score 2 if 1-3 small joints (with or without involvement of large joints)  
• Score 3 if 4-10 small joints (with or without involvement of large joints) 
• Score 5 if >10 joints (at least 1 small joint)   
B. Serology (at least 1 test result is needed for classification) 
• Score 0 if negative RF and negative ACPA 
• Score 2 if low-positive RF or low-positive ACPA 
• Score 3 if high-positive RF or high-positive ACPA 
C. Acute-phase reactants (at least 1 test result is needed for classification) 
• Score 0 if normal C-reactive protein (CRP) and normal erythrocyte 
sedimentation rate (ESR) 
• Score 1 if abnormal CRP or abnormal ESR 
D. Duration of symptoms 
• Score 0 if <6 weeks 
• Score 1 if ≥6 weeks 
 8 
 
Similar to the 1987 criteria, the 2010 criteria utilize the presence or absence of RF, a 
high-affinity autoantibody directed against the fragment crystallizable (Fc) portion of 
immunoglobulin, as one of the domain. In addition, the 2010 criteria utilize the 
presence or absence of ACPA. 
 
 
2.2 ENVIRONMENTAL RISK FACTORS 
 
2.2.1 Cigarette smoking 
One established environmental risk factor for RA is cigarette smoking.
1
 A large number 
of case-control studies
42-56
 and fewer cohort studies
57-62
 have shown that cigarette 
smoking is directly associated with the risk of developing RA. Previous analyses 
examined primarily smoking status (current, former and never smokers)
42 45 48 50 51 55-61
 
and lifelong exposure to smoking analyzed as pack-years of smoking.
43 44 46 47 52-54 59 60
  
 
Less attention has been given to other important aspects of cigarette smoking, such as 
the number of years a person has smoked (duration),
47 59 62
 the mean number of 
cigarettes smoked (intensity)
47 49 57 59 61 62
 and smoking cessation.
47 59 60
 Only one 
prospective cohort study simultaneously addressed all aspects of duration, intensity and 
lifetime smoking, as well as smoking cessation.
59
 Results concerning duration and 
intensity of smoking have shown that the risk of RA increases in a dose-response 
manner. However, it is not clear if light smoking is also associated with an increase in 
RA risk.  
 
A meta-analysis published in 2010 showed that in men the risk of RA was doubled 
among current smokers compared to never smokers, while it was 30% higher among 
women who were current smokers.
63
 The meta-analysis also showed that cigarette 
smoking increases the risk of RA significantly especially among heavy smokers (more 
than 20 pack-years of cigarette smoking) and the risk of RF-positive RA. 
 
Experimental data suggest that smoking is involved in RA development through a 
triggering mechanism, thus implying that a small amount of cigarette smoking 
theoretically may be enough to induce RA.
64 65
 This causal model has been presented 
for ACPA positive RA cases. In detail, when the lung encounters smoke, macrophages 
are activated and some cells go into apoptosis, necrosis, or both. This process could 
lead to increased citrullination in certain proteins in the lungs, a process that changes 
the aminoacid arginine to citrulline. Therefore proteins result with a different charge, 
leading to a different folding and an additional sensitivity to degradation. Some of these 
modified proteins bind specifically to MHC class II molecules on antigen-presenting 
cells, such as dendritic cells or macrophages that contain the shared epitope peptide-
binding motif. Moreover, smoking might further contribute to T-cell and B-cell 
activation by triggering antigen presenting cells in the lung, thus enhancing cell-cell 
interactions, like T-cell receptor with MHC class II or CD40 ligand with CD40, that 
finally results in a high quantity of ACPA antibodies. 
 
   9 
2.2.2 Alcohol 
Among lifestyle factors, alcohol has been the most studied in association with RA. In 
fact, long-term consumption of alcohol in moderate amounts may affect immune 
function and could down regulate production of pro-inflammatory molecules involved 
in the development of RA.
66-68
  
 
The first epidemiological study to analyze this association was a hospital based case-
control study among women in the Netherlands,
49
 that observed a reduced risk of RA 
associated with alcohol consumption. However, subsequent studies (2 case-control and 
2 prospective cohort studies) did not observe any association between alcohol and 
RA.
54 69-71
 In 2008 the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) 
group examined the association of alcohol consumption with RA in both their case-
control study and in the Danish Case-Control Study on Rheumatoid Arthritis 
(CACORA), observing an inverse association with RA.
72
 After the EIRA study, two 
other case-control studies reported an inverse association as well.
73 74
  
 
The accumulated evidence on the association between alcohol consumption and RA 
risk has been quantitatively summarized in two recent meta-analyses and clearly 
indicates a protective role of moderate consumption of alcohol (<15 grams per day) in 
the development of RA.
75 76
 Results from paper III of this thesis were included in these 
meta-analyses. 
 
 
2.2.3 Physical activity 
Physical activity has an important role in the prevention, management, and 
rehabilitation of a variety of diseases. Research has gradually provided data regarding 
the amount of physical activity, and particularly the energy expenditure caused by it, 
that is necessary to prevent the development of various diseases,
77 78
 including 
cardiovascular disease (CVD).
79
 Only one prospective cohort study has analyzed the 
potential role of physical activity in preventing RA, but found no association between 
exercise and risk of RA.
70
 
 
In patients with RA, physical activity appears to be beneficial for maintaining joint 
flexibility.
80 81
 Moreover, physical activity improves aerobic capacity, muscle function, 
bone density, daily activity performance and quality of life, exactly as in healthy 
persons.
82-84
 Some studies have also shown that moderate-intensity exercise is not 
associated with progression of joint destruction.
82 85
 Physical activity and exercise are 
only used as secondary prevention in patients with RA.  
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2.2.4 Diet 
Diet has been evaluated in several studies for its role in the management of established 
RA,
86
 while fewer studies have examined diet in relation to the development of RA.
87
 
 
2.2.4.1 Fish  
Fish consumption is considered protective against several chronic diseases, including 
cancer
88-90
 and cardiovascular diseases.
91 92
 Few observational studies (4 case-control 
and 3 prospective cohort studies) have analyzed the association between fish 
consumption and RA, and results are mixed.
69 93-98
 Two hospital-based case-control 
studies conducted in Greece have reported a lack of association between fish 
consumption and RA.
95 96
 In contrast, a population-based case-control study observed a 
statistically significant reduced risk of RA among women who consumed 2 or more 
servings of broiled or baked fish per week.
98
 The EIRA study, a large population-based 
case-control study conducted in Sweden,
97
 and the Diet, Cancer and Health (DCH)
69
 
cohort study found a modest decrease in risk of total RA with consumption of oily fish, 
while the Nurses’ Health Study did not show an association between total fish and 
RA.
93
  
 
2.2.4.2 Meat 
Meat consumption is an important dietary source of protein and essential nutrients 
including iron, zinc and vitamin B12. However, there is accumulating evidence that red 
meat consumption increases the risk of cardiovascular diseases
99 100
 and colon 
cancer.
101 102
 Epidemiological studies (1 case-control and 2 prospective cohort studies) 
have reported a lack of association with RA.
69 93 98
 
 
2.2.4.3 Dairy products 
Dairy products is a broad term used to indicate milk and products derived from milk, 
including yogurt, cheese, cream, and butter. Only two studies have examined dairy 
product consumption in relation to RA risk. A case-control study conducted in 
Washington reported  no association between dairy products and milk beverages and 
risk of RA.
98
 In contrast, the Iowa Women’s Health Study, a prospective cohort study, 
reported an inverse association between total dairy products and risk of RA.
103
 
 
2.2.4.4 Fruits and vegetables 
Fruits and vegetables play an important role in diet due to their protective action against 
several chronic diseases.
104 105
 Fruits and vegetables could play a role in reducing the 
risk of RA, especially thanks to their high content of antioxidant nutrients.  
 
Studies on the association between fruits and vegetables and RA are limited, and results 
are not consistent. A case-control study and the Diet, Cancer, and Health cohort study 
found no association between fruit and vegetable consumption and RA risk.
69 98
 A more 
recent case-control study in Greece found an inverse association between cooked 
vegetables and RA, but no association with raw vegetables.
95
 An inverse association, 
although not statistically significant, was observed in the Iowa Women’s Health Studies 
between fruit and vegetable consumption and RA.
106
 Among fruits, oranges and 
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grapefruit juice consumption showed the lowest relative risks, while among vegetables, 
cruciferous vegetable consumption was associated with the lowest risk.  
 
2.2.4.5 Coffee and tea 
Coffee and tea are two of the most consumed beverages in the world.  
 
An increase in RA risk associated with high coffee intake was observed in a 
prospective cohort study in Finland
71
 and in a matched case-control study conducted in 
Denmark.
46
 However, other cohort studies failed to replicate these results. The Black 
Women’s Health Study (BWHS),
107
  the Iowa Women’s Health Study,
108
 the Nurses’ 
Health Study,
109
 and the Danish Diet, Cancer and Health cohort
69
 reported no 
association with RA for total or caffeinated coffee intake.  
 
Studies that have also examined decaffeinated coffee intake, have found an increase in 
RA risk associated with this beverage.
107 108
 The reason could lie in the use of solvents 
in the decaffeination process of coffee beans that may play a role in the development of 
RA.
110
  
 
It is hypothesized that tea has both anti-oxidative and anti-inflammatory properties,
111
 
but results from observational studies on RA are mixed. The Iowa Women’s Health 
Study observed a decreased risk of RA with high consumption of tea,
108
 while the 
Nurses’ Health Study found no association.
109
 In contrast, the Black Women’s Health 
Study found a positive association between tea consumption and RA.
107
 
 
2.2.4.6 Nutrients 
Foods provide the human body with essential nutrients, that are utilized to survive and 
grow. Few studies have examined the role of different nutrients in the prevention of 
RA. 
 
Long-chain n-3 polyunsaturated fatty acids (PUFAs), commonly known as long-chain 
omega-3, are mainly found in fish. Indeed, the observed inverse association between 
fish consumption and RA risk has been attributed to their content of long-chain n-3 
PUFAs. The n-3 PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
are metabolized to competitive inhibitors of n-6 PUFAs (prostaglandins and 
leukotrienes) and suppress the production of the inflammatory cytokines, such as TNFα 
and interleukin 1β,
112
 involved in RA development. However, only two studies have 
directly examined these nutrients and found no association.
69 98
  
 
Dietary vitamin D is also found mainly in fish. Some studies have indicated that 
vitamin D may reduce the development of autoimmune diseases.
113 114
 The prospective 
Iowa Women’s Health Study reported an inverse association between both dietary and 
supplemental vitamin D intake and RA.
103
 However, other studies were not able to 
confirm these findings.
69 115 116
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Adequate levels of selenium are important for immunity, and selenium is also involved 
in regulating excessive immune responses and chronic inflammation.
117
 Two nested 
case-control studies conducted in Finland analyzed the serum concentrations of 
selenium in men and women with and without RA.
118 119
 An elevated risk of RA was 
observed for low levels of selenium, but the association was not statistically significant.  
 
Fruits and vegetables are rich in antioxidants that may protect against oxidative stress. 
Products of free radical oxidation are present in the synovial fluid of patients with RA, 
indicating a role of free radicals and oxidative stress in the RA inflammation process.
120 
121
 Among the four studies examining associations between antioxidants and RA,
69 98 106 
122
 only one prospective study observed an inverse association.
106
 The association 
between antioxidants and RA was also examined using serum antioxidant 
concentrations in three studies. Two nested case-control studies conducted in Finland 
118 119
 observed an elevated risk of RA for low levels of serum α-tocopherol, and β-
carotene, but none of the associations were statistically significant. A case-control study 
in Washington County, Maryland, analyzed the difference in serum concentration of α-
tocopherol and β-carotene between RA cases and controls, finding a statistically 
significant decrease only for β-carotene.
123
 A randomized, double-blind, placebo-
controlled trial conducted in US, The Women’s Health Study, also evaluated vitamin E 
supplementation and found no association with RA.
124
 
 
 
2.2.5   Other factors  
Occupational silica dust has been shown to be associated with RA in the EIRA study.
125
 
Other epidemiological studies have linked the association of occupations such as 
drilling, mining, and sand blasting with increased RA risk due to exposure to silica 
through the respiratory tract.
125-128
 In addition, substantial exposure to inhaled organic 
solvents in occupations such as upholstering, hair-dressing, and concrete work has been 
associated with risk of RA.
129
 
 
Hormones are related to both incidence and clinical expression of RA. Women are two 
to four times more likely than men to develop RA.
130 131
 Use of oral contraceptives has 
been inversely associated with RA in most studies, but not all.
132
 The role of breast 
feeding is not clear: the Nurses’ Health Study showed an inverse association with 
duration of breast feeding,
133
 and two other studies confirmed the inverse association,
134 
135
 however one study showed a positive association.
136
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3 AIMS 
 
The overall aim of this thesis was to evaluate the association between lifestyle factors 
and diet and risk of rheumatoid arthritis. 
 
The specific aims were: 
 
• To evaluate the association between cigarette smoking and risk of developing 
rheumatoid arthritis in a large population of Swedish women, with attention to 
specific characteristics of smoking including duration, intensity and cessation 
(Paper I), and by summarizing the published evidence in a dose-response meta-
analysis (Paper II). 
  
• To prospectively estimate the association between alcohol consumption and 
rheumatoid arthritis in the Swedish Mammography Cohort (Paper III). 
 
• To analyze the long-term consumption of alcohol in association with risk of 
rheumatoid arthritis (Paper III). 
  
• To evaluate the association between dietary intake of long-chain n-3 
polyunsaturated fatty acids and risk of rheumatoid arthritis in the Swedish 
Mammography Cohort (Paper IV). 
 
• To analyze the long-term consumption of long-chain n-3 polyunsaturated fatty 
acids (Paper IV), as well as the long-term consumption of fish (Paper IV) in 
association with rheumatoid arthritis. 
 
• To analyze the association between physical activity and risk of rheumatoid 
arthritis in the Swedish Mammography Cohort (Paper V). 
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4 SUBJECTS AND METHODS 
 
4.1 STUDY POPULATION 
This thesis is based on data from the Swedish Mammography Cohort (SMC), a cohort 
study of Swedish women established in 1987.137  
 
Between March 1987 and December 1990, all women living in Uppsala (n=48 517) 
and Västmanland County (n=41 786) and born between 1914 and 1948 were invited to 
participate in a population-based mammography screening program. The invitation 
included a six-page questionnaire with question regarding alcohol intake and diet (67-
item food frequency questionnaire (FFQ)), parity, weight, height and educational status. 
The response rate was 74% (n= 61 433) (Figure 4).  
 
In the fall of 1997 a second questionnaire was sent to women who were still alive 
(n=56 030). The 1997 questionnaire collected information regarding alcohol and diet 
(96-item FFQ), and additional information regarding dietary supplements, physical 
activity, cigarette smoking and anthropometric measures including body weight across 
the life course. The response rate was 70% and after exclusion of women with incorrect 
or missing personal identification number the final 1997 cohort consisted of 38 984. 
Women who answered the 1997 questionnaire were the study base of Paper I, III, IV 
and V. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The Swedish Mammography Cohort study populations for Paper I, III, IV 
and V. The length of each bar represent the follow-up time for each study. 
 
 
 
 
 
1987 1997 2003 2009 2010 
1st FFQ 
N=61 433 
2st FFQ 
N=38 984 
Paper III, n=34 141 
Paper IV, n=32 232 
Paper V, n=30 112 
Paper I, n=34 101 
Start of 
follow-up 
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4.1.1 Exclusions 
From the 37 239 women still alive at start of follow-up (1
st
 January 2003), all women 
diagnosed with a non-RA joint condition (ICD-10 codes M07-M12, M14, M45, M46, 
M30-M36) were excluded (1899 women in Paper III and 2052 women in Paper I, IV 
and V). The diagnoses considered for exclusion were psoriatic and enteropathic 
arthropathies, juvenile arthritis, gout, other arthropathies, and systemic connective 
tissue disorders, such as systemic lupus erythematosus. The reason for this exclusion is 
because of the difficulty in the diagnosis of RA, a disease that can be misdiagnosed as 
other joint conditions in early stages. Moreover, in Paper I, III and V, women who did 
not answer the questions regarding cigarette smoking status (n=797), drinking status 
(n=440) and leisure-time activity (n=4705) were excluded from the analysis. Women 
with extreme energy intake (i.e. 3 standard errors from the mean value on the log-
transformed scale) were also excluded (n=502 in Paper III and n=496 in Paper IV). 
Moreover, women who consumed fish oil supplements (n=2167) were excluded from 
the main analysis in Paper IV, but included in sensitivity analysis. 
 
 
4.2 EXPOSURES ASSESSMENT 
 
Smoking 
In the 1997 questionnaire a section regarding cigarette smoking, that was not included 
in the 1987 questionnaire, was introduced. The questions regarding smoking included 
current smoking status at the time of filling in the questionnaire, the year they started 
smoking, and the year of smoking cessation. Moreover, a question regarding the 
number of cigarettes smoked per day was included, with the option to report current 
intensity of smoking as well as intensity at different ages. 
 
In Paper I different variables were considered in order to cover all aspects of cigarette 
smoking. Smoking status was categorized as never, former and current smoker. 
Intensity of cigarette smoking was calculated as the lifetime average number of 
cigarettes per day, while duration was calculated as the number of years a woman had 
smoked during her life, for both former and current smokers. Intensity and duration of 
smoking were categorized into tertiles and relative risks were calculated using never 
smokers as the reference group. Smoking cessation was evaluated using the number of 
years since quitting smoking and the age at smoking cessation. Moreover, a variable 
that took into account the lifetime exposure to cigarettes smoking (pack-years) was 
calculated. Pack-years were calculated by multiplying the average number of cigarettes 
smoked per day by the number of years the person had smoked, divided by 20 (number 
of cigarettes in one pack). Pack-years of smoking was categorized into quartiles. 
 
Alcohol 
The average number of glasses of alcoholic beverages per week, defined as 15 grams of 
ethanol, corresponding to approximately 500mL of beer, 150 mL of wine, or 50 mL of 
liquor was calculated using five questions from the 1987 FFQ (Paper III). Women 
were asked to indicate their average consumption over the previous six months of beer 
(0.5%, 2.8% and 4.5% alcohol by volume), wine (12.5% to 14.5% alcohol), and liquor 
(40% alcohol). 
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The section of the 1997 FFQ with information on alcohol consumption included 
questions on status of alcohol drinking (from which the variable alcohol status was 
derived), year since quitting drinking, frequency of beer (2.8% and 4.5% alcohol), wine 
(less and more than 18% alcohol (fortified wine)), and liquor (40% alcohol) drinking. 
Eight predefined response categories were provided ranging from “never” to “three or 
more times per day”. Moreover, a question regarding the amount of drinking per 
occasion was included (Figure 5). Also, an open ended question collected information 
regarding the daily or weekly consumption of light beer (0.5% alcohol). 
 
 
   20. How often do you drink alcohol? 
          I have never had alcohol 
 I stopped drinking alcohol at the age of        Y 
 
 Times per month ... week ... day 
  I usually drink Never 0-1 2-3 1-2 3-4 5-6 1 2 3+ 
Beer 2,8% alc.          
Beer 4,5% alc.          
Wine          
Wine >18% alc.          
Liquor 40% alc.          
21. How much do you drink on each occasion? 
Beer    Cl Wine   cl Liquor   Cl 
             
             
1 can of beer=33/50 cl, bottle of wine/liquor=75 cl, 1 dl=10 cl 
 
Figure 5. Questions used in the 1997 food-frequency questionnaire to assess alcohol 
consumption in the Swedish Mammography Cohort  
 
 
In Paper III, to evaluate the association between alcohol consumption and risk of RA, 
women were categorized as never drinkers, former drinkers, occasional drinkers (≤2 
glasses of alcohol per week), and regular drinkers (>2 glasses of alcohol per week) 
according to 1997 consumption. Moreover, the number of glasses per week was 
analyzed as a four level variable, from less than 1 or never to more than 4 glasses per 
week. Relative risks for consumption of beer, wine and liquor were reported separately 
and mutually adjusted. Moreover, an analysis regarding the long-term consumption of 
alcohol was performed by combining information about number of glasses of alcohol 
per week from the 1987 FFQ and the 1997 FFQ. 
 
Diet 
In 1987 the FFQ included questions regarding 67 food items. The eight predefined 
responses ranged from “never or seldom” to “four or more times per day”. Total fish 
consumption in 1987 was calculated using two questions, one regarding the 
consumption of fatty fish (salmon, mackerel, herring) and the second on consumption 
of other types of fish (Paper IV). 
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The 1997 FFQ was more comprehensive and included 96 food items. In this 
questionnaire participants reported their average frequency of consumption of each 
food item during the previous year. Eight predefined response categories were provided 
ranging from “never” to “three or more times per day”. There were also additional open 
questions regarding dairy foods, coffee, tea, light beer, soft drinks, sugar/honey, and 
bread. The 1997 questionnaire, moreover, collected information on the use of dietary 
supplements, such as multivitamins and fish oil supplements. Total fish consumption in 
1997 was calculated using three questions based on the consumption of 
herring/mackerel, salmon/whitefish, and cod/saithe/fish fingers.  
 
Intake of individual nutrients was calculated by multiplying the average frequency of 
consumption of each food by the nutrient content of age-specific portion sizes. Values 
for each nutrient amount in foods was obtained from the Swedish National Food 
Administration Database.
138
 The Swedish National Food Agency database is based on 
analyses of representative foods on the Swedish market. For prepared foods and dishes 
cooking losses are taken into consideration. The database is considered to be virtually 
complete with regard to the Swedish food supply (2071 foods and dishes are included – 
of which 196 are fish/seafood items and 407 are meat/poultry items). Nutrient intakes 
were adjusted for total energy intake through the use of the residual method.
139
 
 
In Paper IV long-chain n-3 polyunsaturated fatty acids (PUFAs) intake was calculated 
by summing the intake of eicosapentaenoic acid (EPA C20:5), docosapentaenoic acid 
(DPA C22:5), and docosahexaenoic acid (DHA C22:6). Dietary intake of long-chain n-
3 PUFAs in the study population derived mainly from fish consumption: 74.16% of 
total EPA dietary intake, 42.46% of DPA, and 67.08% of DHA was contained in fish. 
To calculate the long-chain n-3 PUFA intake, the portion-size of salmon was 
considered, according to mean values from a total of 5922 days of weighted food 
records kept by 213 randomly selected women of the SMC, as 72 g among women 
aged ≤63 years, 66g among women aged 64-71 and 63g among women aged ≥72, 
while the portion size of codfish was 94 g among women aged ≤63 years, 116g among 
women aged 64-71 and 116g among women aged ≥72. This variable was categorized in 
two different ways: in a multi-category model it was categorized in quintiles, while in a 
threshold model two categories were used, ≤0.21 grams per day and more than 0.21 
grams per day (0.21g/day was the first quintile of the distribution on long-chain n-3 
PUFAs). A long-term analysis was performed combining information regarding long-
chain n-3 PUFAs and total fish consumption from the 1987 and 1997 FFQ. In this 
analysis, long-term n-3 PUFAs was categorized as in the threshold model, while fish 
consumption was categorized as less than one serving per week and one or more 
servings per week. 
 
Physical activity 
Information regarding physical activity was collected on the 1997 questionnaire. There 
were five questions regarding different daily activities and women reported their 
current level of activity as well as their physical activity when they were 15, 30 and 50 
years old. The first question inquired about the number of hours per day dedicated to 
home/household work. The six predefined answers ranged from less than one hour per 
day to more than eight. The second question asked about physical activity in regards to 
type of work/occupation, and the six predefined answers ranged from work requiring 
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mostly sitting down to heavy manual labor. Two questions covered leisure time 
activities such as walking/cycling (six answers ranging between hardly ever to more 
than 1.5 hours per day) and exercise (five answers from less than one hour per week to 
more than five hours per week). Another question covered leisure-time inactivity such 
as watching TV/reading (five answers from less than one hour per day to more than six 
hours per day). A final open-ended question was about the number of sleeping hours 
per day. 
 
In Paper V the variables regarding physical activity were analyzed separately. 
Moreover, a combined variable for leisure-time activity was constructed as the 
combination of minutes per day of walking/cycling and weekly hours of exercise. The 
combined variable had four levels according to the combination of less or more than 20 
minutes per day (min/day) of walking/cycling and less or more than 1 hour per week of 
exercise. A second combined variable was calculated as total energy expenditure. The 
24-hour energy expenditure score was calculated by adding the products of duration 
and intensity, expressed as metabolic equivalent (MET, kcal/kg per hour), for each type 
of physical activity and inactivity, including sleep. 
 
 
4.2.1 Validation  
The reproducibility and validity of the FFQs have been assessed for foods, nutrients, 
dietary supplements by comparison with diet records and biological markers.
140-142
 The 
validity of the FFQ was also assessed among men using multiple 24-hour recall 
interviews.
143
 
 
A validation of the 1987 FFQ was performed by comparing the four one-week 
weighted dietary records (three to four months apart) in a random sample of 184 
women from the SMC cohort.
140
 The validity of alcohol intake, as measured by 
correlation coefficient, was 0.9 (Paper III). In the same subgroup, the correlation 
between the FFQ-based estimation of EPA and DHA (Paper IV) and their relative 
content in adipose tissue was 0.46 and 0.45 respectively.
141
 
 
The validity of the 1997 FFQ has been evaluated in 248 middle-aged and elderly men 
(40-74 year old) from the Cohort of Swedish Men (COSM) who received the same 
questionnaire in 1997 that was sent to the women in the SMC. The estimates of alcohol 
intake (Paper III) based on the 1997 FFQ had good validity compared with 14 
interviews that measured 24-hour recall of intake (correlation coefficient of 0.81).
143
  
The validity of EPA and DHA (Paper IV) estimates were 0.64 and 0.60 
respectively.
143
 The validity of the estimate of long-chain n-3 PUFA intake from the 
1997 FFQ was further examined in a sub-cohort of the SMC. Adipose tissue was 
obtained in 2003-2004 from 239 randomly selected women, aged 55-75, and the 
validity was 0.41.
142
 The validity of leisure-time activity and inactivity estimates 
(Paper V) was assessed comparing the questionnaire with 7-day activity records.
144
 
The correlations were 0.42 and 0.52 respectively. 
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4.2.2 Missing data 
The use of self-administered questionnaires is a way to reduce costs related to 
interviewer-related instruments. However, they are also less easily monitored and more 
susceptible to misunderstanding of questions and non-response, leading to missing data.  
 
In this thesis missing data regarding the exposure was handled in two different ways. In 
Paper I, III and V, women who did not answer questions regarding cigarette smoking 
status, drinking status and leisure-time activity were excluded from the analysis. We 
therefore focused only on the women who reported information on the exposure of 
interest.  
 
In Paper III and IV, a second approach was also considered, treating non-response as 
“zero consumption”. This approach is based on the work of Hansson et al,
145
 who 
analyzed missing data from a 56-item FFQ sent to participants of a case-control study 
in Sweden. 58% of cases and 50% of controls were contacted for a telephone interview, 
during which they were asked to provide all the omitted information. The proportion of 
actual non-consumption among missing reports was 74.1% for alcoholic beverages and 
82% for total fish. This approach was used in Paper III when analyzing frequency of 
beer, wine and liquor consumption, and in Paper IV to calculate total fish consumption 
and intake of long-chain n-3 PUFAs. In particular, if a more conservative approach 
were used, the long-chain n-3 PUFAs nutrient would have been treated as missing 
whenever the information concerning one of its component or source items was 
missing, leading to an unacceptable loss of information. 
 
For example, focusing only on 65 predefined questions regarding average consumption 
of foods in the 1997 FFQ, only 6.4% of the women in the SMC cohort who were still 
alive at the start of follow-up (1 January 2003) completed this section without reporting 
any missing value. In this section the median number of missing values was 4, 25% of 
the women did not answer 12 questions out of 65, and only 164 women did not report 
any answer (Figure 6).  
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Figure 6. Number of missing values reported in one section of the food-frequency 
questionnaire, consisting of 65 questions with 8 predefined answers. 
 
 
 
4.3 CASE DEFINITION 
 
4.3.1 The Patient Register 
The Swedish National Inpatient Register (IPR) of the National Board of Health and 
Welfare (NBHW) is a collection of information regarding inpatients at public hospitals 
in Sweden. The IPR started in the 1960’s, but only since 1987 includes all inpatient 
care in Sweden.  
 
From 2001, the IPR was joined by the National Outpatient Register (OPR) that contains 
data on outpatient specialist visits, including day-surgery and psychiatric visits from 
both public and private caregivers. Primary care from general practitioners is not yet 
covered in the Swedish registers. 
 
Coverage of the OPR was assessed at approximately 80% in 2007. In 2011 an external 
review and validation of the IPR was conducted.
146
 The study reported that 99% of all 
somatic and psychiatric hospital discharges were registered in the IPR and a primary 
diagnosis was listed for 99% of all discharges. The review of the validity found positive 
predictive values (PPVs) of 85-95% for most diagnoses given in the IPR, with a PPV 
for RA of 95.9%. In a study based on the hospital discharge register, almost one 
thousands medical records were validated, and a validity (ICD-codes for RA vs. the 
American College of Rheumatology (ACR) criteria) of approximately 90% was 
found.
147
 Similarly, in ongoing and past studies based on the OPR, approximately 200 
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medical records were scrutinized. A high validity of the register-based RA diagnosis, 
close to 90%, was found.
148
 
 
 
4.3.2 The Swedish Rheumatology Register 
The Swedish Rheumatology Register (SRR) was initiated in 1995 and collects 
information from rheumatologists in Sweden on newly diagnosed patients with RA and 
patients on biologic treatments. In recent years, patients with established RA, patients 
with long symptom duration at diagnosis and other rheumatologic diseases, regardless 
of treatment, have been included. The SRR has been estimated to include 
approximately 50% of all newly diagnosed patients with RA in Sweden.
149
 
 
 
4.3.3 Identification of incident cases 
Linkage to the registers was made using the Swedish Personal Identity Number 
(PIN).
150
 The Swedish personal identity number (date of birth combined with a unique 
four digit number, e.g. 19470102-0259) serves as a unique identifier in Swedish health 
care, and in many other areas of the Swedish society (e.g. taxes). This linkage method 
allows for a virtually 100% coverage of the Swedish health care system.  Although 
typing mistakes are possible when recording patients information, data from the SMC 
were checked for consistency in the PIN number with the information from the register 
(date of birth and gender of the person and an inbuilt control internal number to check 
for correctness) and the error rate was less than 1 per 5000 persons.  
 
RAis is a disease for which the onset and the diagnosis could differ by several months. 
A study has estimated that the median lag time between onset of RA symptoms and the 
first rheumatologist’s encounter is 17 months.
151
 Therefore, early identification of 
incident RA cases is difficult. Incident cases of RA were identified as the first diagnosis 
code for RA (ICD-10 codes M05 and M06). 
 
The main source used to identify newly diagnosed RA cases within the SMC was the 
OPR, since the SRR had a coverage of only 50% and RA is not a disease that usually 
leads to hospitalization in its first stages. For this reason, the start of follow-up had to 
be delayed in comparison to the data collection in 1997. The start of follow-up, 
however, could not correspond to the start of the OPR, in 2001. An additional two-
years delay in the start of follow-up was in fact necessary to remove all prevalent cases 
that were registered for the first time when the OPR started. Figure 7 shows the pick of 
first diagnosis identified in 2002 in the OPR for this reason. Longer delays were 
considered (start of follow-up in 2004 and 2006) in sensitivity analyses. 
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Figure 7. Number of incident cases identified in the Inpatient and Outpatient Registers.  
 
 
For cases with a first diagnosis in both OPR and SRR, information was merged and the 
earlier date of diagnosis was used. Moreover, using information from the SRR, cases 
were excluded if date of first symptoms and date of diagnosis were more than 365 days 
apart.  
 
The IPR, that includes data on hospitalization, was used only to identify prevalent cases 
of RA, therefore for exclusion of prevalent RA cases from the cohort at the start of 
follow-up. Newly diagnosed RA cases identified through the IPR during the follow-up 
period were considered as prevalent cases and therefore excluded from the cohort. 
However, the inclusion of these cases was considered in sensitivity analyses. 
 
Deaths occurring in the cohort were identified through the Swedish Death Register. 
 
 
4.4 STATISTICAL METHODS 
 
4.4.1 Survival analysis 
Survival analysis is the analysis of the time to the occurrence of an event, which in this 
thesis was the diagnosis of RA. Rather than analyzing the probability density function 
of the time to event T, f(t), or its cumulative distribution F(t), survival analysis usually 
considers the survival function, S(t), and the hazard function, h(t). 
 
The survival function is the complement of the cumulative distribution function: 
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The survival function is defined as the probability of surviving beyond a given time t, 
i.e. the probability that there is no event before time t. The function is equal to 1 at time 
0 and decreases towards 0 as t goes to infinity. 
 
The hazard function h(t) is: 
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The hazard function can be interpreted as the instantaneous event rate at time t, 
conditional on survival up to time t. The hazard is not a probability and can vary 
between 0 and infinity. Over time the hazard can increase, decrease, fluctuate, or 
remain constant.  
 
Sometimes it is not possible to determine the time of the failure event, at least not for 
every subject. For example, during the study period, subjects are followed up and data 
are collected. If during the follow-up period a subject does not experience the event or 
is lost to follow-up, then that observation is called “censored”. 
 
 
4.4.1.1 Cox Model 
To analyze censored survival data the Cox proportional hazards regression model was 
used in this thesis.
152
 The model define the hazard for the j-th subject as 
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where 8
"
!%" denotes an unspecified baseline hazard, x is the vector of the covariates, 
and β is the vector of the parameters of the model. Results from a Cox model are given 
in terms of hazard ratio (HR, also called relative risk in this thesis), comparing one 
subject to another:   
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The Cox model is a linear model for the log of the hazard ratio, a fact that simplifies the 
estimation and the interpretation of the β parameters.  
 
The Cox model is based on the assumption that the hazards are proportional. Therefore, 
the ratio of the two hazards does not depend on time, t. To test this important 
assumption of the model the Schoenfeld’s residuals method was used. This method 
tests the hypothesis of a zero slope for a model of the Schoenfeld’s residuals (difference 
between the observed value and the estimated value from the model) as a function of 
time.
153
 Other ways to test the proportionality assumption are graphical methods or the 
inclusion of an interaction term between a covariate and the survival time. 
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4.4.1.2 Age as time-scale 
Typically in cohort studies, the time-scale used in Cox regression model is time-on-
study, i.e. the follow-up time or time since baseline. It is however possible to use age as 
time-scale, where subjects enter the analysis at their baseline age and exit at their event 
or censoring age. The use of age as time-scale is an efficient way to adjust the model 
for it. By using age as the time-scale, it is not necessary to assume a parametric model 
for the relationship between age and the outcome. For example, whether age is included 
in the model as a continuous variable or as a categorical variable could affect the 
results. Instead, the use of age as time-scale is a non-parametric way to adjust for it. 
 
4.4.1.3 Restricted cubic splines 
To model the dose-response relationship between the exposures and RA, restricted 
cubic splines were used in Paper I and IV. Restricted cubic splines consist of three or 
more polynomial segments with boundaries called knots. Between consecutive knots 
the curve is a cubic polynomial, and a straight line before the first knot and after the last 
knot. 
 
A restricted cubic spline Cox proportional hazards model with q knots can be written as  
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where the spline covariates f1, f2, fq-1 are transformation of x that depend on the original 
variables x, the knots, and the distances between knots. 
 
4.4.1.4 Probabilistic sensitivity analysis 
In the appendix of Paper I, III, IV and V a probabilistic sensitivity analysis was 
performed to evaluate possible changes in the estimates due to bias in the definition of 
incident cases of RA. The possible misclassification of prevalent cases as incident cases 
has been considered and the uncertainty about the amount of misclassification has been 
modeled in a priori distribution, in the form of a uniform distribution with values that 
range from 0 to 20 (a maximum of 20% of misclassified cases was considered 
appropriate). Simulations were performed with 200 random draws from the a priori 
distribution: each draw corresponded to the percentage of prevalent cases that should be 
randomly excluded. For each draw the corresponding relative risk was calculated, and 
from the distribution of relative risks obtained the median relative risk and the standard 
deviation were calculated. 
 
The probabilistic sensitivity analysis was performed in each study considering different 
pattern of exclusions. For example, in Paper IV, we considered three patterns of 
exclusions:  
 
• Cases excluded randomly from all categories, as if the prevalent cases did 
not change their eating habits due to the disease 
• Cases excluded only from the lower category, as if the prevalent cases were 
all decreasing the consumption of foods rich in long-chain n-3 PUFAs 
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• Cases excluded only from the upper category, as if the prevalent cases were 
all increasing the consumption of foods rich in long-chain n-3 PUFAs. 
 
Similar patterns were assumed in Paper I, III and V for smoking, alcohol intake and 
physical activity. 
 
4.4.1.5 Statistical Software 
All the survival analysis using Cox models and the probabilistic sensitivity analyses 
were performed in SAS, version 9.2. The dose-response analyses presented in Paper I 
and IV were conducted in Stata, version 11.1. 
 
 
 
4.4.2 Population Attributable Risk 
The population attributable risk (or population attributable fraction) indicates the 
proportion of cases that would not occur in a population if the risk factor were 
eliminated. It can be calculated as:   
 
./+	 # 	
.
+
	6++
+
% $7
=$	1 	.
+
	6++
+
% $7>	
				?
 
where  Pe is the prevalence of the exposure and RRe is the relative risk of the disease 
due to the exposure. 
 
The equivalent of the population attributable risk when analyzing a protective factor is 
the population prevented fraction, calculated as  
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4.4.3 Meta-analysis 
In the last few years the number of published articles has grown exponentially (see 
Figure 8). According to PubMed, the number of medical articles published between 
1960 and 1970 was around 1 million, while in the last decade the number of articles 
published was more than 8 million. 
 
 
 
 
Figure 8. Number of medical articles published divided in decades, according to 
PubMed 
 
 
The scientific information has become difficult to handle, and researchers may have 
problems drawing conclusions based on such a large amount of results, often based on 
different methodologies. Meta-analysis is a tool to combine and summarize results 
from studies with disparate research methods and findings. 
 
This method was invented in 1904 by the mathematician Karl Pearson to summarize 
results on the effectiveness of inoculation against typhoid fever.
154
 However, the term 
meta-analysis was first used in 1976, when Glass presented the methodology to the 
American Educational Research Association annual meeting.
155
 In the last two decades 
the number of meta-analyses has grown, and extensive research regarding the 
underlying methods has been conducted.  
 
The main aim of a meta-analysis is to combine the results of different studies into one 
single estimate. When performing meta-analysis it is possible to choose between two 
methods: a fixed-effect model, in which it is assumed that there is a true effect size 
common to all studies, and a random-effects model, in which it is allowed to the true 
effect size to differ between studies. In the random-effects model the effect estimates in 
the studies are considered a random sample from a particular distribution of the true 
effect size and therefore the combined estimate is the mean of this distribution. 
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To combine the results from different studies, it is first necessary to assign a weight to 
each study. In the majority of the meta-analyses the weights are assigned based on the 
inverse of the overall study error variance (1/variance). Therefore, a high weight is 
assigned to studies with a precise estimate of the population relative risk (low 
variance), while a low weight is given to studies with a less precise estimate of the 
population relative risk (high variance). Under the fixed-effect model, the weight of the 
study i is the inverse of the within-study error variance (Vi): 
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Under the random-effects model, there are two sources of variance that need to be 
taken into account: the within-study variance Vi specific for each study and the 
between-study variance τ
2 
that is common to all the studies. Therefore, the weight is 
defined as: 
 
1
,
#
$
2
,
1 	 3-
 
 
Under the random-effects model the confidence interval of the combined effect will 
always be wider and the weights will always be more similar to each other than under 
the fixed-effect model due to the inclusion of the between-study variance. 
 
The combined log-relative risk is given by the weighted mean across all studies: 
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where k is the number of studies included in the meta-analysis. 
 
 
 
The variance is calculated as: 
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and the standard error (SE) is given by:  
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In Paper II this approach was used to summarize the relative risk estimates in the 
highest category of pack-years of smoking versus never smokers. However, the 
relationship between a continuous exposure and an outcome may take on different 
shapes (e.g. linear, U-shaped, J-shaped). Epidemiological studies therefore often group 
the exposure variable into more than two categories. A tool to summarize dose-
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response results has been described in a paper by Greenland and Longnecker in 1992
156
 
and is called a dose-response meta-analysis.  
 
The first stage of a two-stage dose-response meta-analysis is to estimate the dose-
response trend within each study using a log-linear model where the dependent variable 
is the logarithm of the relative risk as function of the exposure dose:  
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where y is the n x 1 vector of adjusted relative risks and X is the n x p matrix 
containing the values of the dose (excluding the reference level) and/or some 
transformation of it (e.g. splines, polynomials). The relative risks presented in each 
study are not independent, since they share the same reference exposure level. 
Therefore, the covariance matrix ; of the error terms is comprised of the variance of 
each log-relative risk on the main diagonal and the non-zero covariance between log-
relative risks estimates in the off-diagonal elements.   
 
The aim of the second stage is to combine the study-specific trend estimates using 
established methods for multivariate meta-analysis.
157-159
 A dose-response meta-
analysis is presented in Paper II. 
 
4.4.3.1 Heterogeneity 
The studies included in a meta-analysis can differ on many levels, from the study 
design to the study population, from the exposure assessment to the number of 
confounding variables adjusted for. Such diversity is usually referred to as 
heterogeneity, and could cause the observed discrepancies in the results of the studies.  
 
The classical measure of heterogeneity is the Cochran’s Q statistic 
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which is distributed as a χ
2
 distribution with m-1 degrees of freedom, where m is the 
number of study included in the meta-analysis. However, if the p-value obtained from 
this statistic is large (e.g. >0.05) we can conclude only that the test did not detect a 
problem with the model, not that the problem does not exist. Moreover, the Q test has 
low power (it is more likely that the test will be statistically non-significant), especially 
when the number of studies is small, i.e. most meta-analyses.
160
  
 
Another statistic that is widely reported to quantify heterogeneity is I
2
, which is the 
percentage of total variation attributable to heterogeneity. It is calculated as: 
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where df is the number of degree of freedom of the Q statistic. A value of 0% indicates 
no observed heterogeneity, and larger values indicate increasing heterogeneity.  
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4.4.3.2 Publication bias 
Meta-analyses are based on a systematic review of the relevant literature. In Paper II, 
MEDLINE (PubMed) and EMBASE databases were searched and relevant papers were 
identified to be included in the meta-analysis. The studies were selected based on well 
specified criteria, inherent to the relevance of each study for the meta-analysis and the 
accuracy of exposure and outcome definition, as well as the possibility of extracting the 
information needed for the analyses (i.e. relative risks and their 95% confidence 
intervals). 
 
A problem of meta-analyses is the so called publication bias. Publication bias is the 
association of publication probability with the statistical significance of the study 
results, i.e. studies with statistically significant results are more likely to be published as 
compared to papers with negative findings.  
 
One of the techniques used to assess publication bias is the funnel plot. The funnel plot 
is a graphical representation of the precision in the estimation of the treatment effect, 
increasing as the sample size of component studies increases. Results from small 
studies will scatter at the bottom of the graph. In the absence of publication bias, the 
plot will resemble a symmetrical, inverted funnel. Instead, the more asymmetrical is the 
graph, the more likely it is that the publication bias is substantial. An example of funnel 
plot is reported in Figure 9, where we can observe symmetry, indicating no evidence of 
publication bias. 
 
 
Figure 9. Funnel plot of the studies included in the meta-analysis on the association 
between pack-years of smoking and rheumatoid arthritis (Paper II) 
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A way to statistically evaluate the symmetry of the funnel plot is the Egger’s test.
161
 
The Egger test is based on the estimate of a linear regression of the log relative risks on 
their standard errors, weighting by 1/(variance of the log relative risks). Under the null 
hypothesis of no publication bias, the regression line would be vertical in the funnel 
plot. In Paper II there was no evidence of asymmetry, i.e. no evidence of publication 
bias. 
 
4.4.3.3 Statistical Software 
The meta-analyses reported in Paper II were performed with Stata, version 12.1, using 
the command metan to summarize the relative risks estimates of women and men in the 
higher category of pack-years of smoking vs. never smokers from the included studies. 
To perform the dose-response meta-analysis the command glst
162
 and mvmeta
163
 were 
used.  
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5 RESULTS 
 
The Swedish Mammography Cohort with baseline in 1997 includes data on 38 984 
women. Due to the limitations that the data sources imposed (described in section 
4.3.3), the follow-up in Paper I, III, IV and V started 1 January 2003 and therefore the 
study population was limited to the 35 187 women still alive and that did not developed 
rheumatoid arthritis (RA) or non-RA joint conditions before 2003. In this cohort 224 
women developed RA before 31 December 2010 (end of follow-up in Paper I, IV and 
V).  
 
 
5.1 CHARACTERISTICS OF THE STUDY POPULATION 
The median age of the study participants in 1997 was 60 years (range 48-83). 
Regarding cigarette smoking, 23% of women were current smokers at the time of the 
questionnaire, and 23% were former smokers, with a median smoking intensity of 10 
cigarettes per day. Swedish women drank a median of 4.35 grams of alcohol per day, 
with only 10% of the population drinking on average more than 1 glass per day of 
alcohol (15 grams of alcohol). Moreover, women in the SMC cohort were moderately 
active, with 70.5% of women walking or bicycling more than 20 minutes per day and 
56.9% of women exercising one hour or more per week. 
 
Comparing the 1987 FFQ and the 1997 FFQ, 64% of the women remained in the same 
category of fish consumption, therefore maintaining stable fish consumption over the 
10 year period. Regarding alcohol consumption, 57% of the women kept their alcohol 
intake stable. 
 
 
5.2 MAIN RESULTS 
 
5.2.1 Cigarette smoking and rheumatoid arthritis (Paper I) 
During the follow-up period, between 1 January 2003 and 31 December 2010 (254 996 
person-years), 219 RA cases were identified among 34 101 women included in the 
study cohort. Among cases, 37% of women were current smokers, while in the whole 
cohort the prevalence of current smokers was 23%.  
 
The risk of RA was doubled for women who were current smokers at the time of the 
questionnaire (RR=2.20, 95% CI: 1.58-3.04) and it was 68% higher for former smokers 
(RR=1.68, 95% CI: 1.19-2.38) compared to never smokers. All characteristics of 
smoking, such as intensity, duration and pack-years, were associated with an increased 
risk of RA, even for the lowest levels of the exposure (Figure 10).  
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Figure 10. Relative risk of rheumatoid arthritis by smoking status, intensity, duration, 
and pack-years of cigarette smoking among ever smokers and years since quitting 
smoking among former smokers in the Swedish Mammography Cohort, 2003-2010. 
Adjusted for age (continuous), menopause status (pre-/post-menopause), parity (0, 1, 2, ≥3 children), alcohol use (none, former, 
current), educational level (less than high school, high school, university), and BMI (quartiles). Intensity, duration and pack-years 
were not mutually adjusted
164
. 
 
 
Compared to never smokers, women who stopped smoking at least 15 years before the 
start of the follow-up still had a two-times higher risk of developing RA. Results 
regarding smoking cessation that were adjusted for smoking duration were still 
statistically significant (Table 1). 
 
 
Table 1. Multivariable adjusted relative risk* and 95 percent confidence interval of 
rheumatoid arthritis by duration and years since quitting smoking in the Swedish 
Mammography Cohort, 2003-2008 
 
   Years since quitting smoking 
 Cases Never  
smokers 
Cases 1-14 
Years 
Cases >14  
Years 
Duration       
      Never smokers 79 1.00 (ref)  -  - 
      1-20 years  - 1 0.78  
(0.11-5.65) 
29 1.81 
(1.15-2.82) 
      >20 years  - 19 1.55 
(0.93-2.59) 
10 2.08 
(1.06-4.05) 
Adjusted for age (continuous), menopause status (pre-/post-menopause), parity (0, 1, 2, ≥3 children), alcohol use (none, former, 
current), educational level (less than high school, high school, university), and BMI (quartiles). 
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5.2.2 Alcohol and rheumatoid arthritis (Paper III) 
Among the 34 141 women included in this study, 197 developed RA during the follow-
up period (from 1 January 2003 to 31 December 2009; 226 032 person-years). The 
percentage of women who developed RA that were occasional drinkers (≤2 drinks per 
week) in 1997 was 53%, and 33% were regular drinkers (>2 drinks per week), 
compared to 49% and 34.5% of the whole cohort. 
 
Occasional drinkers were used as the reference group in the analysis of the risk of RA 
related to alcohol status since they were the largest group. No difference in the risk of 
RA was observed among never drinkers when compared to occasional drinkers, while 
regular drinkers had a 19% lower risk of RA (RR=0.81, 95% CI:  0.59-1.11), although 
non statistically significant. The analysis regarding the number of glasses of alcohol per 
week showed that women who consumed more than 4 glasses per week, compared to 
the reference group of women who drank 1 or less glass per week, had a 37% lower 
risk of RA (RR=0.63, 95% CI:  0.42-0.96) (Figure 11). The analysis were adjusted 
only for smoking, since the inclusion in the Cox model of additional covariates such as 
body mass index (BMI), educational level, parity, menopausal status, and consumption 
of meat and dairy products did not change the estimate (RR=0.65, 95% CI: 0.43-0.99), 
but slightly reduced the statistical power of the analysis (wider confidence intervals). 
 
 
Figure 11. Relative risk and 95% confidence interval of rheumatoid arthritis by number 
of glasses of alcohol per week in 1997 in the Swedish Mammography Cohort, follow-
up 2003-2009. 
Adjusted for age (continuous), and smoking status (categorized as never, former, current ≤10 cigarettes/day or >10 cigarettes/day). 
Additional adjustment for BMI, educational level, parity, menopausal status, meat and dairy products consumption did not change 
the estimates. Median number of glasses per week in the highest category = 6 
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The estimated relative risk for women who drank more than 4 glasses of alcohol per 
week compared to women who consumed one or less glass per week was different 
among current smokers and never smokers. The relative risk was 0.77 (95% CI: 0.41-
1.47) among current smokers, while it was 0.38 (95% CI: 0.15-0.97) among never 
smokers. However, there was no statistical interaction between smoking and alcohol. 
 
Results regarding beer, wine and liquor consumption showed a similar level of 
reduction in RA risk for all three types of alcoholic beverages, supporting the 
hypothesis of a possible protective effect of alcohol against RA. 
 
 
5.2.3 Long-chain n-3 PUFA and rheumatoid arthritis (Paper IV) 
During the follow-up period (from 1 January 2003 to 31 December 2010; 241 120 
person-years) 205 newly diagnosed cases of RA were identified among the 32 232 
women included in the final study cohort. The variable regarding the long-chain n-3 
PUFAs’ was divided according to the quintiles of its distribution. The first quintile of 
the distribution was 0.21 grams per day (corresponding to more than 70 grams per 
week of salmon or 500 grams per week of cod) and women with a lower level of intake 
were considered as the reference group. The reference group included 27% of cases and 
20% of the entire cohort.  
 
The multivariable adjusted relative risks of RA were between 0.62 and 0.70 for 
quintiles 2 to 5 compared to the reference group. A threshold model in which the first 
quintile was used as threshold indicated a 35% decreased risk (95% CI: 0.48-0.90) 
comparing women with an intake of more than 0.21 grams per day of long-chain n-3 
PUFAs to women with a lower intake. The risk among women who reported in 1987 an 
intake of long-chain n-3 fatty acids higher than 0.21 grams per day was 33% lower 
(RR=0.67, 95% CI 0.51-0.88) compared to women with a lower intake.  Levels of EPA 
intake higher than 0.1 grams per day also reduced the risk of RA, but the estimates 
were not statistically significant (Table 2). DHA was not associated with risk of RA. 
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Table 2. Relative risk of rheumatoid arthritis in relation to dietary eicosapentaenoic 
(EPA) and docosahexaenoic acid (DHA) intake among 32 232 women in the Swedish 
Mammography Cohort, follow-up 2003-2010 
 
 
 
No. of cases 
Multivariable-
adjusted  
RR† ‡ (95% CI) 
EPA
§
   
<0.06 53 1.00 
0.06-0.085 38 0.75(0.41-1.37) 
0.085-0.108 40 0.82(0.37-1.82) 
0.108-0.152 34 0.47(0.18-1.23) 
≥ 0.152 40 0.66(0.21-2.05) 
DHA
§
   
<0.123 53 1.00 
0.123-0.171 39 0.89(0.49-1.62) 
0.171-0.216 32 0.74(0.33-1.66) 
0.216-0.290 43 1.41(0.55-3.62) 
≥ 0.290 38 1.13(0.36-3.56) 
 
† RR= relative risk, CI= confidence interval 
‡ Adjusted for age (continuous), cigarette smoking (never, former, current ≤10 cigarettes/day or >10 cigarettes/day), alcohol intake 
(never, former, current <2 drinks/week, ≥2 drinks/week), use of aspirin (yes, no), and intake energy (quintiles).  
§ 
Estimates of EPA and DHA were based on data from the food-frequency questionnaire in 1997 
 
 
 
There was a slight decrease in RA risk associated with fish consumption. The risk was 
lower for consumption of more than one serving per week of lean fish (Table 3), 
although none of the estimates were statistically significant. After adjustment for long-
chain n-3 PUFAs the inverse association disappeared for both total and fatty fish, while 
it was attenuated for lean fish, and remained non statistically significant.  
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Table 3. Relative risk of rheumatoid arthritis by fish consumption in the Swedish 
Mammography Cohort, 2003-2009 
 
 
 
No. of women 
in the cohort
 
No. of 
cases 
Multivariable-
adjusted  
RR † (95%CI) 
Multivariable-
adjusted  
RR ‡ (95%CI) 
 Fish, servings per week     
<1  11927 78 1.00 1.00 
1-2 9569 63 0.93 (0.66-1.30) 1.14 (0.77-1.68) 
>2 10736 64 0.88 (0.63-1.24) 1.14 (0.70-1.84) 
 Fatty Fish, servings per week     
<3 times/month 13461 89 1.00 1.00 
0.5-1 times/week 12084 81 0.95 (0.70-1.30) 1.22 (0.80-1.86) 
>1 6687 35 0.83 (0.55-1.24) 0.95 (0.50-1.79) 
Lean Fish, servings per week     
Never 3219 24 1.00 1.00 
≤1  15170 99 0.81 (0.52-1.28)  0.86 (0.55-1.35) 
>1 13843 82 0.78 (0.49-1.24) 0.86 (0.53-1.40) 
 
† Adjusted for age (continuous), energy (quartiles), alcohol status (categorized as never, former, sporadic (2 or less drinks per week), 
and regular drinkers (more than 2 drinks per week), use of aspirin (yes, no), and smoking status (categorized as never, former, 
current ≤10 cigarettes/day or >10 cigarettes/day). 
‡ Additionally adjusted for long-chain n-3 polyunsaturated fatty acids. 
 
 
 
5.2.4 Physical activity and rheumatoid arthritis (Paper V) 
Among the 30 112 women included in the study cohort, 201 had a first diagnosis of RA 
during the study period (from 1 January 2003 to 31 December 2010; 226 477 person-
years). Among the cases 14.2% were in the lowest category of leisure time-activity, 
while  9.7% of the women in the whole cohort were in this group. Only 7% of women 
in the cohort walked more than 1.5 hours per day and only 11.3% exercised more than 
5 hours per week. 
 
Women who combined 20 or more minutes per day of walking/bicycling with 1 or 
more hour per week of exercise had a 35% decreased risk of developing RA (RR=0.65, 
95% CI: 0.43-0.96) (Figure 12). None of the single physical activities analyzed 
separately was statistically significantly associated with risk of RA. However, there 
was a decrease in risk for hours of home/household work (32% decrease for more than 
6 hours per day), hours of exercise per week (20% decrease for 2 or more hours per 
week), walking/standing at work (15% decrease compared to sitting), and duration of 
walking/bicycling per day (9% for 20 or more minutes per day). Moreover, there was 
an increased RA risk among women in the high category of inactive leisure-time (27% 
increase for more than 2 hour watching TV/sitting per day). Women with a daily 
energy expenditure of less than 35.3 MET-hours/day (5
th
 percentile of the distribution) 
had a 75% increased risk of RA (RR= 1.75, 95% CI: 0.97-3.17). 
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Figure 12. Multivariable-adjusted relative risk and 95% confidence interval of 
rheumatoid arthritis by leisure-time activity in the Swedish Mammography Cohort, 
follow-up 2003-2010. 
Adjusted for age (continuous), smoking status (categorized as never, former, current ≤10 cigarettes/day or >10 cigarettes/day), 
alcohol intake (never, former, current <2 drinks per week, ≥2 drinks per week), body mass index (quartiles), and educational level 
(<10, 10-12, >12 years, other).  
 
 
 
5.3 ANALYSES OF LONG-TERM EXPOSURES 
 
In Paper III and Paper IV analyses of long-term exposures were performed by 
combining information from the 1987 and 1997 questionnaires.  
 
In Paper II, women were divided according to their alcohol consumption (never 
drinkers, 3 or fewer glasses per week of alcohol, and more than three glasses) in both 
1987 and 1997. The resulting variable had 9 levels, of which two did not include any 
participants (never drinkers in 1997 and ≤3 glasses per week or >3 in 1987), since 
women who reported being never drinkers in 1997 were also never drinkers in 1987. 
Never drinkers in both 1987 and 1997 were used as the reference group. The risk of RA 
was 52% lower (RR=0.48, 95% CI:  0.24-0.98) among women who drank more than 3 
glasses per week in both 1987 and 1997 (Figure 13). 
 
1.00
0.72
0.59
0.65
0.30
0.50
1.00
2.00
R
e
l
a
t
i
v
e
 
R
i
s
k
Walking <20 m/d Walking >=20 m/d
Leisure-time activity
Exercise <1 h/w Exercise >=1 h/w
 38 
 
Figure 13. Multivariable adjusted relative risks of rheumatoid arthritis by weekly 
alcohol intake in 1987 and 1997 in the Swedish Mammography Cohort, follow-up 
2003-2009 
 
 
In Paper IV, both long-chain n-3 PUFA dietary intake and fish consumption were 
analyzed taking into account information from the 1987 and 1997 questionnaires. 
Long-term intake of more than 0.21 grams per day of long-chain n-3 PUFAs was 
associated with a 52% decrease in RA risk (RR=0.48, 95% CI: 0.33-0.71). Also the 
total consumption of one or more serving of fish per week in both 1987 and 1997 was 
associated with a 29% decrease in the risk of RA, but the estimate was not statistically 
significant (95% CI: 0.48-1.04). Moreover, after adjusting for long-chain n-3 PUFA 
intake, the inverse association disappeared (RR=1.14, 95% CI: 0.70-1.87). This result 
supports the hypothesis of previous studies that a possible protective role of fish against 
RA is mainly attributable to its content in long-chain n-3 PUFAs. 
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5.4 SENSITIVITY ANALYSES 
 
5.4.1 Alternative definitions of start of follow-up 
In Paper I, III, IV and V sensitivity analyses were performed to test the assumption 
regarding the identification of incident RA cases. In the main analyses, newly 
diagnosed cases of RA were identified from the Outpatient Register (OPR) and the 
Swedish Rheumatology Register (SRR) and the follow-up period started in 2003. 
However, these decisions could be questionable and could have led to misclassification 
of the outcome, with inclusion of prevalent cases as incident cases. To evaluate if these 
assumptions have in some way influenced the results, other assumptions were taken 
into consideration. 
 
First, the start of follow-up was delayed from 2003 to 2004 and subsequently to 2006. 
The gap between 2001, start of the OPR, and 2003, start of follow-up, could have not 
been enough to avoid the inclusion of prevalent cases that were not yet included in a 
national register. Therefore, wash-out periods of 3 and 5 years were considered and the 
results did not show differences when compared to the main analysis (Figure 14). 
 
 
Figure 14. Multivariable adjusted relative risks and 95% confidence intervals for 
analyses performed with three different starts of follow-up period by number of glasses 
of alcohol per week in the Swedish Mammography Cohort 
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Newly diagnosed cases identified during the follow-up period through the Inpatient 
Register (IPR) were excluded from the analyses and considered as prevalent cases, 
since RA is a disease that in first stages does not usually lead to hospitalization. It is 
possible that this assumption could have been too strict, and therefore two additional 
models were considered, with the inclusion of the cases identified using the IPR. Two 
different start of follow-up dates were considered (2003 and 2004) and again results did 
not show remarkable differences. 
 
 
5.4.2 Presence of prevalent cases  
To evaluate the direction of the bias due to the inclusion of prevalent cases as incident 
cases, a probabilistic sensitivity analysis was conducted. Results from these sensitivity 
analyses for Paper I, III, IV and V, reported in their respective appendix, did not show 
significative changes in the results and therefore supported the conclusions of each 
paper. 
 
The maximum amount of prevalent cases included was set to 20%. However, this cut-
off could have been too low. Results from an additional sensitivity analysis with a 
maximum inclusion of 40% of prevalent cases are presented in Table 4 for long-chain 
n-3 PUFAs. Estimates were similar under assumption 1 (prevalent cases did not change 
eating habits) and 3 (prevalent cases increased their consumption of foods rich in long-
chain n-3 polyunsaturated fatty acids), while they were slightly increased under 
assumption 2 (prevalent cases decreased their consumption of foods rich in long-chain 
n-3 polyunsaturated fatty acids). However, it is more likely that prevalent cases did not 
change or increase consumption of fish rather than decreased it.  
 
 
Table 4. Median values‡ and standard deviation of the distributions of RA relative 
risks by dietary long-chain n-3 polyunsaturated fatty acids intake according to three 
alternative assumptions about the behavior of prevalent cases among incident cases  
 
 
 
1. Prevalent cases did not change eating habits; 2. Prevalent cases decreased their consumption of foods rich in long-chain n-3 
polyunsaturated fatty acids; 3. Prevalent cases increased their consumption of foods rich in long-chain n-3 polyunsaturated fatty 
acids. 
 
 
Long-chain n-3 
polyunsaturated fatty 
acids‡ 
Assumption 1 Assumption 2 Assumption 3 
≤0.21 g/d 1.00 1.00 1.00 
0.22-0.29 g/d 0.62±0.07 0.76±0.05 0.62±0.002 
0.30-0.37 g/d 0.63±0.07 0.76±0.05 0.63±0.004 
0.38-0.49 g/d 0.69±0.07 0.86±0.05 0.71±0.004 
>0.49 g/d 0.66±0.07 0.82±0.05 0.55±0.04 
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5.4.3 Missing values 
In this thesis, partial non-response for foods items was considered as non-consumption 
and therefore considered as zero.
145
 This hypothesis was tested in each paper through 
sensitivity analyses. In Paper IV, the long-term fish consumption was analyzed 
excluding women who did not respond to questions regarding fish consumption: results 
did not change, but wider confidence intervals were observed (Table 5). 
 
 
Table 5. Multivariable adjusted relative risk and 95% confidence intervals of 
rheumatoid arthritis by long-term consumption of fish during 1987 and 1997, after 
exclusions of women with missing values for fish consumption 
 
§
 Adjusted for age (continuous), cigarette smoking (never, former, current ≤10 cigarettes/day or >10 cigarettes/day), alcohol intake 
(never, former, current <2 drinks/week, ≥2 drinks/week), use of aspirin (yes, no), red meat consumption (quartiles), dairy food 
consumption (quartiles), and energy intake (quartiles). 
 
 
 
5.4.4 Fish-oil supplements (Paper IV) 
In Paper IV women who used fish oil supplements were excluded from the main 
analysis, since the main focus of the paper was on dietary intake of long-chain n-3 fatty 
acids. A sensitivity analysis was performed including those women in the cohort who 
consumed fish oil supplements. Among a total of 34 399 women, 6.3% used fish oil 
supplements, while the prevalence of fish oil supplements consumption was 7.7% 
among women with RA (n= 222). In this sensitivity analysis the relative risk estimates 
for long-chain n-3 PUFAs were similar (RR=0.62, 95% CI: 0.41-0.93). The use of fish 
oil supplements was not associated with the development of RA. Due to the lack of 
information from the questionnaire, however, it was not possible to evaluate the effect 
of dose, duration, and composition of the supplements on RA. 
 
 
 
 
 
 
 
 
 
 Cases 
Multivariable-
adjusted  
RR (95%CI) 
Cases 
Multivariable-
adjusted  
RR (95%CI) 
   
  Intake 1987 
Fish§ Intake 1997  <1 serving/week  ≥1 serving/week 
<1 serving/week 22 1.00 14 0.72 (0.37-1.42) 
≥1 serving/week 44 1.04 (0.62-1.75) 83 0.71 (0.44-1.15) 
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5.5 POPULATION ATTRIBUTABLE RISK 
 
The population attributable risk for current smokers was 0.22, therefore 22% of the 
cases would not have occurred in the population if all women were non-smokers (or 
former smokers) (Paper I). 
 
The population prevented fraction in Paper IV was 0.28 and corresponded to the 
proportion of the hypothetical total load of the disease that has been prevented by 
exposure to more than 0.21 grams per day of long-chain n-3 PUFAs. The population 
prevented fraction was 0.25 for exposure to long-term intake of more than 0.21 grams 
per day of long-chain n-3 PUFAs and was 0.13 for long-term consumption of one or 
more servings per week of fish. The population prevented fraction calculated for 
leisure-time activity (Paper V) was 0.22 and for consumption of more than 4 glasses 
per week of alcohol (Paper III) was 0.08.  
 
 
 
5.6 META-ANALYSIS (PAPER II) 
 
The meta-analysis presented in Paper II was based on an extensive search of PubMed 
and EMBASE databases. Twenty-nine studies reported an estimate of the association 
between cigarette smoking and RA. Of these, only 3 cohort studies
165-167
 and 7 case-
control studies
46 52 54 168-171
 reported an estimate of the association between lifelong 
exposure to cigarette smoking, expressed as pack-years, and risk of RA. Results from 
Paper I of this thesis were included in the meta-analyses presented in Paper II. All the 
studies included were evaluated in terms of quality using the Newcastle–Ottawa 
Quality Assessment Scale (NOQAS) for cohort and case-control studies, and each 
study was judged based on the selection of the study groups, the comparability of the 
groups, and the ascertainment of the exposure and the outcome. The score ranged 
between 0 (poor) and 9 (excellent), and all studies included in Paper II scored between 
5 and 8. 
 
The dose-response relationship between pack-years of cigarette smoking and risk of 
RA was modeled using a restricted cubic spline model. The non-linear dose-response 
trend (Figure 15) showed a statistically significant increased risk of developing RA 
with an increasing number of pack-years smoked up to 20 pack-years, and then the 
relative risk stabilized approximately around the value of two.  
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Figure 15. Non-linear dose-response relationship between pack-years of cigarette 
smoking and relative risk of rheumatoid arthritis based on summary of available 
evidence. 
Relative risk (solid line) and 95% confidence interval (long dashed lines) from the restricted cubic splines model. The short dashed 
line represents the RR from the linear model. Estimates reported in the table are based on the median value of each category. 
 
 
The dose-response analysis was supported by a comparison of the highest vs. the 
lowest categories of pack-years reported in each study. All studies reported as the 
reference level never smokers, while the median of the highest category ranged 
between 15 and 55 pack-years. The analysis showed a twofold increase of RA risk 
comparing the highest category of pack-years to never smokers (RR=2.02, 95% CI: 
1.75-2.33). 
 
There was no evidence of heterogeneity (Pheterogeneity = 0.32) or publication bias (p-value 
from the Egger’s regression asymmetry test was 0.10). 
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6 DISCUSSION 
 
6.1 METHODOLOGICAL CONSIDERATIONS 
The objective of an epidemiological study is to obtain an accurate estimate of the 
association of an exposure on the occurrence of a disease in the source population of 
the study. Moreover, a further objective is to obtain an estimate that can be generalized 
to relevant target populations. 
 
Accuracy in the estimation implies that the value of the parameter that is the object of 
measurement is estimated with little error. The errors in the estimation process are 
classified as random or systematic. Below follows a discussion of the types of errors 
that may have influenced the results of the papers included in this thesis. 
 
 
6.1.1 Random error 
Random error is often referred to as chance or random variation and can be defined as 
variability in the estimates that cannot readily be explained. A main component of 
random error is the process used to select the specific study subjects, called sampling. 
There is always a random variation in the estimate between samples.  
 
An estimate with little random error (also called chance or random variation) may be 
described as precise. Statistical precision is often taken as the inverse of the variance of 
the measurements and therefore can be improved by increasing the sample size. In this 
thesis, precision was measured through 95% confidence intervals. If the confidence 
interval does not include the null value (RR=1), it is unlikely that the observed 
association is due to chance. The main results presented in this thesis were statistically 
significant, indicating that chance is an unlikely explanation for the observed 
associations.  
 
In Figure 16, the statistical power has been plotted against different hazard ratios. From 
the graph it is possible to notice how the power rapidly decreases for hazard ratios that 
are near the null value.    
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Figure 16. Statistical power associated with given hazard ratios according to number of 
cases in two sensitivity analyses from the Appendix of Paper IV. 
 
 
 
6.1.2 Systematic error 
Systematic errors in estimates are commonly referred to as biases. The validity of a 
study is usually separated into two components: internal validity and external validity 
(or generalizability). Most of the violations to internal validity can be classified as 
confounding, selection bias, and information bias. 
 
6.1.2.1 Confounding 
Confounding may be considered as the alteration of the effect of the exposure under 
study due to the effect of another factor that is mixed with the real exposure effect. The 
distortion introduced by a confounding factor can be large, and can lead to 
overestimation or underestimation of an effect. Formally, a factor can be considered a 
confounder of an association if (Figure 17): 
 
• Is an independent risk factor for the disease 
• Is associated with the exposure under study in the source population 
• It cannot be an intermediate step in the causal path between the exposure and 
the disease.
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Figure 17. Directed Acyclic Graph (DAG) of the concept of a confounder. 
 
 
In order to control for confounding, the potential confounders are added to the 
estimation model to adjust the estimate. 
 
In Paper I, III, IV and V, many possible confounders have been taken into 
consideration and have been adjusted for in the model. However, only confounders that 
changed the beta coefficient by more than 5% were included in the final model, 
whereas the other variables were excluded. Age was accounted in the model as the 
time-scale, thus no assumption was made regarding the association between age and 
RA, since age was modeled in a non-parametric way and therefore error due to 
mismodeling was minimized. 
 
Smoking was the main confounder of the associations presented in Paper III, IV and 
V. A possible interaction was evaluated in Paper III between alcohol consumption and 
smoking, but the interaction was not statistically significant. However, a difference in 
risk of RA was observed when the analysis was stratified by smoking status. 
  
Confounding variables may be affected by measurement error. This error could lead to 
residual confounding, meaning that the association is still confounded even after the 
confounder is adjusted for in the analysis. Moreover, the possibility that unmeasured 
confounding may have influenced the observed results should be taken into 
consideration. For example, it is not possible to rule out that the findings were observed 
because of confounding by family history of RA, a potential confounder of the 
associations under study in this thesis, due to both shared genes and shared 
environmental factors. The inability to adjust for family history of RA is a limitation of 
these studies. 
 
6.1.2.2 Selection bias 
Selection bias is a distortion of the effect that may result from the procedures that have 
been used to select the study subjects or from the factors that influence the decision to 
participate in a study. A common consequence is a difference in the relation between 
exposure and disease among those who participated to the study and those who were 
eligible.
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Selection bias is a minor problem in prospective cohort studies because exposed and 
unexposed subjects are free from the disease at the time of enrollment. However, 
selection bias could arise if there is a difference in completeness of follow-up among 
exposed and unexposed. The virtually complete follow-up of participants in the SMC 
through linkage to various population-based registries minimizes this possibility. 
 
6.1.2.3 Information bias 
Information bias arises when the exposure or the outcome are not measured correctly. 
Errors in measurement can be caused by the observer (observer bias), the study 
participants (responder bias), or the instrument (e.g. the questionnaire structure). For 
categorical variables, information bias is often called misclassification, and can be 
classified as differential or nondifferential. 
 
Misclassification is nondifferential when error in measurement of the exposure is not 
related to the outcome, or when error in the classification of the disease is not related to 
the exposure. Bias introduced by nondifferential misclassification can be predicted in 
direction for a binary exposure or outcome, towards the null value. However, when the 
exposure or the outcome have more than two levels, the bias could be either towards or 
away from the null value.
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Differential misclassification can bias the results in either direction. The most common 
differential misclassification is recall bias. Recall bias occurs in case-control studies, 
where cases are likely to recall the exposure differently than the healthy controls. For 
example, cases could over-report the consumption of certain foods considered 
unhealthy, while they could underestimate consumption of healthy foods in order to 
explain the causes of their disease. In this scenario, the bias would overestimate the 
association between diet and disease. 
 
Misclassification of the exposure 
The main exposures analyzed in this thesis (Paper I, III, IV and V) have been assessed 
using the 1997 questionnaire. Measurement error in dietary data derives from normal 
within-person variation in intakes over time and from errors associated with self-
reporting. Due to the prospective design of the studies, in which all the participants 
were free from RA at the start of the follow-up, a possible potential misclassification of 
the exposure is likely to be nondifferential. Nevertheless, RA onset cannot usually be 
considered occurring at the same time of the date of diagnosis as there is likely 
substantial lag time between symptom onset and disease diagnosis. Therefore there is 
the possibility that women with early symptoms of RA could have changed their habits, 
leading to differential misclassification. However, the early assessment of exposure and 
covariates, 6 years before the start of the follow-up, should have helped in minimizing 
the differential misclassification. 
 
Study participants could have under-reported their consumption of alcohol, since 
alcohol drinking can be considered a socially undesirable behavior. However, high 
validity of alcohol intake estimates indicated that the FFQ is a valid and reliable 
instrument of assessment. Similar bias could have occurred for physical activity, of 
which women could tend to over-report, since it is considered a healthy behavior. Also 
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for physical activity, the high validity suggested that this misclassification was 
relatively small. 
 
Misclassification of the outcome 
A possible source of nondifferential misclassification of the outcome may be the 
inclusion of prevalent cases as incident cases. In this situation, the misclassification is 
nondifferential, since the error is not related to the exposure of interest. This situation 
has been extensively evaluated through the use of simulations, and the consistency of 
the results supported that even if this bias was present, it had a small effect on the 
estimates. 
 
6.1.2.4 External validity (generalizability) 
The Swedish Mammography Cohort is a population-based cohort, where participants 
were invited from the general population of central Sweden. The response rate was 
74% in 1987 and 70% in 1997. Since the 1997 questionnaire was sent only to women 
who answered to the 1987 questionnaire, only approximately 52% of the eligible 
women answered the 1997 questionnaire. Although this response rate could seem low, 
the study cohort well represents the entire Swedish population of middle-aged and 
elderly women, in terms of age, BMI and educational level distribution (Table 6). 
However, results from the SMC, a cohort of middle aged and elderly women, cannot be 
generalized to younger women or to men. Moreover, the Swedish population is mainly 
Caucasian and the generalizability of these results to other ethnic population should be 
made with care.   
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Table 6. Comparison of the Swedish Mammography Cohort (SMC) with the Swedish 
population in 1997 for women aged 48-83 years, regarding age distribution, educational 
level, and body mass index (data from the Official Statistics Sweden). All values are 
percentages. 
 
 
Characteristics SMC 1997 Female Population, 
aged 48-83 years, 1997 
Age groups, years 
Total, n 38 984 1 633 520 
48-54 28.5 27.6 
55-59 17.9 15.0 
60-64 14.5 12.7 
65-69 13.5 12.7 
70-74 12.4 12.7 
75-79 10.1 12.1 
80-83 2.9 7.3 
   
Education, ages 48-74 years 
Total, n 33 914 1 316 743 
≤12 years 78.9 78.7 
>12 years 20.5 19.9 
 
Body Mass Index (>25 kg/m
2
), by age groups 
45-54 37.6 38.8 
55-64 45.7 47.4 
65-74 49.7 52.0 
75-84 43.0 42.3 
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6.1.3 Meta-analysis 
Meta-analysis is a statistical tool to summarize published results regarding an 
association of interest. However, meta-analysis is affected by many limitations, mainly 
related to the quality of the summarized studies. 
 
First, some meta-analysis, including Paper II of this thesis, summarizes results from 
both prospective cohort and case-control studies. However, these two types of designs 
have many differences, from the different statistical estimate (odds ratio in case-control 
studies, hazard ratio in prospective cohort studies) to different biases. For example, 
case-control studies could be affected by recall bias and selection bias, while 
prospective cohort studies are usually not. 
 
Studies included in a meta-analysis usually account for confounding in different ways. 
Although results from the maximally adjusted model are usually selected, unmeasured 
confounding may still be present and it may have different effects on the results in the 
different studies. Moreover, the difference in the number of covariates adjusted for 
could depend on the study population. In fact, subjects from different studies differ in 
geographical location, gender, race, dietary habits, and many others aspects.  
 
A quality score, the Newcastle–Ottawa Quality Assessment Scale (NOQAS) for cohort 
and case-control studies, was used in Paper II to assess the quality of each study 
included in the meta-analysis based on the selection of the study groups, the 
comparability of the groups, and the ascertainment of exposure and outcome. All 
studies included scored from moderate to high. Nevertheless, this score does not take 
into account the differences in study design. In Paper II a sensitivity analysis was 
performed by stratifying for study design and results were slightly different.  
 
From a statistical point of view, the influence of differences between the studies is 
evaluated by testing heterogeneity. No heterogeneity was observed in the meta-analysis 
presented in Paper II. However, the limited number of studies (only 10) could have 
prevented the detection of heterogeneity.
160
 In addition, publication bias was not 
detected, but the same problem related to power could explain the lack of statistical 
significance of the Egger test. 
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6.2 MAIN FINDINGS AND GENERAL DISCUSSION 
 
6.2.1 Cigarette smoking and rheumatoid arthritis 
Cigarette smoking is one of the few established risk factors for RA. Findings from this 
thesis support the role of smoking in developing RA, indicating a twofold increased 
risk among current smokers. Moreover, all characteristics of smoking were associated 
with risk of RA. In particular, Paper I highlighted that not only heavy smokers were at 
higher risk of RA, but also light smokers. In fact, women with a median intensity of 5 
cigarettes per day had a 2.3 times higher risk of RA compared to never smokers. 
 
Former smokers were also at higher risk of RA. Results showed that even women who 
stopped smoking 15 years before baseline in 1997 had a doubled risk of developing RA 
compared to never smokers. Moreover, age at quitting smoking did not play a role in 
reducing the risk of RA.  
 
The results presented in Paper I are not surprising if seen from a pathogenic point of 
view. In fact, cigarette smoking acts as a trigger of the process called citrullination, that 
in later stages (even after several years) can lead to RA development. The trigger 
process could also explain why smoking cessation did not decrease RA risk compared 
to never smokers. However, this biological mechanism has been mainly related to 
ACPA positive RA, while less is known about the mechanism of smoking in ACPA 
negative RA. Moreover, studies have shown that the association between smoking and 
RA is less strong in ACPA negative and RF negative RA cases.
63
 A limitation of this 
thesis, and in particular of Paper I, is the lack of stratification for RA subtypes (ACPA 
and RF status), due to a limited power. 
 
In Paper I, cigarette smoking was assessed only at a single occasion, using the 
questionnaire sent in 1997. Repeated measurement of the exposure could help to avoid 
possible nondifferential misclassification. In fact, the analyses regarding smoking status 
in 2009 (when a third questionnaire was sent to women living in the study area who 
were still alive in 2009) showed that approximately 50% of the women had quit 
smoking, probably due to medical advice.  
 
In Paper II, a meta-analysis regarding smoking and RA was conducted. In particular, 
the published estimates of the association between lifelong exposure to cigarette 
smoking and risk of RA were summarized. Results from the meta-analysis showed 
similar results to Paper I. The risk of RA increased up to 20 pack-years of cigarette 
smoking and then stabilized to a doubled risk for higher consumption. The risk was 
also statistically significant for light consumption, 1 to 10 pack-years.  
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6.2.2 Alcohol consumption and rheumatoid arthritis 
Results from Paper III showed that RA development was inversely associated with 
alcohol consumption among women in the SMC. In particular, women who consumed 
more than 4 glasses of alcohol per week (median of 6 glasses per week) had a 37% 
lower risk compared to infrequent drinkers (<1 glass per week or never).  
 
Despite that the category associated with the lowest RA risk was the one with the 
highest alcohol consumption in the SMC, conclusions referred to a moderate alcohol 
consumption. The word moderate was chosen because women in the SMC drank little 
alcohol. In fact, the median value of the upper category was 6 glasses per week, less 
than one glass per day, and only 1.4% of women consumed more than two glasses per 
day.  
 
Conclusions on an inverse association of alcohol consumption with RA were supported 
by the analysis of beer, wine, and liquor consumption separately. Results, even when 
not statistically significant, showed a similar decrease in risk for all three types of 
alcoholic beverages. 
 
Consistent long-term alcohol consumption of more than 3 glasses per week over a 
period of more than 10 years was associated with a halved risk of RA. It should be kept 
in mind that levels of alcohol consumption estimated in 1987 and 1997 were different. 
The median alcohol consumption in 1987 was 13.25 grams per week (~1 glass), while 
in 1997 was 30.85 (~2 glasses). The difference can be attributed to an overall increase 
in alcohol consumption among Swedish women. It is unlikely that the structure of the 
1997 questionnaire caused this difference, even if the number of questions used to 
assess alcohol intake in the two questionnaires was different (in 1997 there was an 
additional question regarding the consumption of fortified wine with an alcohol volume 
of >18%). 
 
Studies preceding the publication of Paper III were not consistent regarding the role of 
alcohol in the development of RA. Some case-control studies showed an inverse 
association between alcohol consumption and RA,
46 49 72 73
 while prospective cohort 
studies showed no association.
70 71
 The difference could be attributed to differences in 
the study design, in particular considering that case-control studies could have been 
affected by recall bias. However, previous prospective cohort studies had several 
methodological problems that could explain the discrepancy in results with case-control 
studies and with Paper III of this thesis. In fact, one study
70
 did not adjust the analyses 
for cigarette smoking, an important confounder of the association, and another had a 
very limited number of cases (n=89).
71
 Moreover, a following study,
74
 together with 
two meta-analyses that summarized the published evidence,
75 76
 also showed an inverse 
association. 
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6.2.3 Long-chain n-3 PUFAs and rheumatoid arthritis 
Results from Paper IV showed an inverse association between long-chain n-3 PUFAs 
and RA. In particular, women with a dietary intake of more than 0.21 grams per day in 
both 1987 and 1997 had a halved risk of RA compared to women with a lower intake in 
both years.  
 
The intake of 0.21 grams per day was the cut-off used in the threshold model and was 
also the first quintile of the long-chain n-3 PUFAs distribution in the study population. 
This intake level corresponds to at least one serving per week of fatty fish (~50 grams 
of salmon) or four servings per week of lean fish (~500 grams of cod). However, while 
this fish consumption was medium-low in the SMC, it can be considered medium-high 
in other (non-Swedish) populations where fish consumption is substantially lower.
174
  
 
Average long-chain n-3 PUFAs intake in the SMC was different in 1987 and in 1997 
(0.25 grams per day vs. 0.41 grams per day).
142
 These estimates are not directly 
comparable, since they are based on a different number of food items (67-items in 
1987, 96-items in 1997), and this could explain the difference. However, it is possible 
that the increase in the average long-chain n-3 PUFA intake is related to the increasing 
public attention given to health benefits associated with fatty fish consumption, a main 
source of long-chain n-3 PUFAs. According to statistics from the Swedish Board of 
Agriculture, per capita consumption of salmon (the most commonly consumed fatty 
fish), as well as of canned and processed fish, substantially increased (+43 and 15 %, 
respectively) between the late 1980s and the late 1990s in Sweden, although total fresh 
fish consumption decreased (−10 %).
175
 
 
The observed threshold effect observed in Paper IV is similar to the threshold effect 
observed in a meta-analysis of studies on fish, fish oil and coronary heart disease 
risk.
176
 That meta-analysis observed a threshold level of 0.25 grams per day of long-
chain n-3 PUFAs, similar to the level reported in Paper IV. A similar level of intake can 
be obtained by eating fish twice a week, as recommended by the Swedish Food 
Administration and the American Dietary Guidelines Advisory Committee.   
 
A limitation of Paper IV was the lack of detailed information regarding fish oil 
supplements. From the 1997 questionnaire only information regarding intake (yes/no) 
and number of capsules per week was available. However, these data were not 
sufficient to estimate an intake of long-chain n-3 PUFAs from supplements, since 
information about type of fish oil supplements, and therefore information on the 
content of long-chain n-3 PUFAs, was not asked. Results showed a lack of association 
between fish oil and risk of RA, but the number of cases was limited (n=17). In the 
main analysis, women who consumed fish oil supplements were excluded. In this way, 
the possibility of spurious association due to a mixed effect of long-chain n-3 PUFAs 
from supplements and dietary long-chain n-3 PUFAs was minimized.  
 
The association between fish consumption and risk of RA was also evaluated. There 
was a moderate inverse association between fish consumption in 1997 and risk of RA, 
although not statistically significant. However, after adjustment for long-chain n-3 
PUFAs, the inverse association disappeared. A similar scenario was observed when 
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analyzing long-term consumption of fish. There was a 30% decrease in RA risk among 
women with consumption of one or more serving of fish per week, compared to women 
with a lower consumption at both time points. However, after adjusting for long-chain 
n-3 PUFAs the association disappeared. These results indicate that the potential 
protective effect of fish against RA is completely mediated by its content of long-chain 
n-3 PUFAs. 
 
 
6.2.4 Physical activity and rheumatoid arthritis 
Physical activity is an important health related habit. Many are the articles promoting 
physical activity to prevent obesity and its comorbidities. Physical activities can be 
divided in activities performed during work hours (including housework), leisure time 
activities and leisure-time inactivity, including sitting, watching TV and reading. The 
activities that are easier to modify are leisure-time activity and inactivity. 
 
The analysis of leisure-time activity in the SMC showed that combined exercise of one 
hour or more per week and walking 20 or more minutes per day was associated with a 
35% decreased risk of RA. It was not possible to evaluate higher levels of leisure-time 
activities due to a lack of power, since only 7% of women in the cohort walked more 
than 1.5 hours per day and only 11.3% exercised more than 5 hours per week. 
 
Separate models were used to evaluate the association of each type of physical activity 
with RA risk. Results from a model with all the activities mutually adjusted were 
similar, but shifted towards the null value. None of the relative risk estimates from any 
single activity reached statistically significance. The reason could be related to both a 
limited power and to nondifferential misclassification of the exposure. In fact, women 
who consider physical activity a healthy behavior may tend to over-report it.
177
 
 
Physical activity was also evaluated by calculating total energy expenditure. Twenty-
four hour total energy expenditure was not associated with the risk of RA. However, 
the calculation of total energy expenditure presented in Paper V was only a rough 
estimate based on information regarding only physical activity and number of sleeping 
hours. A more precise estimate of this variable would have included the thermic effect 
of food and more advanced techniques to assess physical activity during the day.
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Assessing physical activity using a questionnaire can lead to high levels of 
misclassification due to over-reporting, as mention before, but also to inability to assess 
precise duration and intensity of these activities. For example, women who reported 20 
to 40 minutes of walking per day could have walked at a leisurely pace or walked very 
fast. However, validity of the estimates of leisure-time activity and inactivity using the 
questionnaire was relatively high, as compared to 7-day activity records.
144
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7 CONCLUSIONS 
 
In this thesis the etiology of rheumatoid arthritis (RA) has been investigated. Results 
from the Swedish Mammography Cohort showed: 
 
• Cigarette smoking is a risk factor for RA. Not only heavy smokers, but also 
light smokers were at higher risk of developing RA as compared to never 
smokers. Smoking cessation can help in reducing the risk of RA, but former 
smokers who stopped smoking even more than 15 years before baseline still 
had a doubled risk compared to never smokers 
 
• Moderate alcohol consumption was associated with reduced risk of RA among 
Swedish women. This finding was not related to a specific type of alcohol. 
 
• Long-term analysis of alcohol consumption based on data from 1987 and 1997 
showed a stronger inverse association compared to estimates based only on data 
from 1997. The risk of developing RA was halved among women with a long-
term alcohol consumption of more than 3 glasses per week. 
 
• Long-chain n-3 polyunsaturated fatty acids (PUFAs) dietary intake was 
inversely associated with the risk of RA. The analyzed model showed a 
threshold effect of long-chain n-3 PUFA dietary intake. 
 
• The risk of developing RA was halved among women with a long-term dietary 
intake of ≥0.21 grams per day of long-chain n-3 PUFAs. Long-term 
consumption of fish was also associated with a decreased risk of RA. However, 
the inverse association disappeared after adjusting for long-chain n-3 PUFAs, 
indicating this nutrient was the main cause of the protective effect against RA 
attributed to fish consumption. 
 
• Leisure-time activity was inversely associated with risk of RA. The analysis of 
single activities showed a moderate decreased risk for physical activities 
(walking, exercising, working, housework) and a moderate increased risk for 
physical inactivity (watching TV/sitting), although none of the estimates were 
statistically significant. 
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8 FUTURE RESEARCH 
 
The results presented in this thesis contribute to the knowledge about the etiology of 
rheumatoid arthritis. Further research should include: 
 
• Large, prospective population-based cohort studies to evaluate the etiology of 
the different sub-types of rheumatoid arthritis. 
 
• Large, prospective population-based cohort studies to evaluate the association 
between dietary factors and risk of rheumatoid arthritis, possibly with collection 
of blood and urine to measure intake of nutrients. 
 
• Previous studies have presented different results depending on the method of 
preparation of foods. Future studies should take into account different methods 
of food preparation, such as raw, cooked, fried, grilled, etc., when analyzing the 
association between foods and risk of rheumatoid arthritis. 
 
• Studies to address the association between high alcohol consumption and risk of 
developing RA. 
 
• Studies to address the potentially important difference between daily 
consumption of a small quantity of alcohol compared to consumption of the 
corresponding moderate amount on one weekly occasion. 
 
• Studies to investigate the potential interaction between environmental factors, 
such as alcohol consumption or diet, and genes. 
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